<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults - Johnson, MI - 2017 | Cochrane Library</title> <meta content="Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults - Johnson, MI - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012172.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults - Johnson, MI - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012172.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012172.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults" name="citation_title"/> <meta content="Mark I Johnson" name="citation_author"/> <meta content="Leeds Beckett University" name="citation_author_institution"/> <meta content="M.Johnson@LeedsBeckett.ac.uk" name="citation_author_email"/> <meta content="Leica S Claydon" name="citation_author"/> <meta content="Postgraduate Medical Institute" name="citation_author_institution"/> <meta content="G Peter Herbison" name="citation_author"/> <meta content="Dunedin School of Medicine, University of Otago" name="citation_author_institution"/> <meta content="Gareth Jones" name="citation_author"/> <meta content="Leeds Beckett University" name="citation_author_institution"/> <meta content="Carole A Paley" name="citation_author"/> <meta content="Airedale NHS Foundation Trust" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD012172.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/10/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012172.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012172.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012172.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Electroacupuncture; Exercise; Fibromyalgia [*therapy]; Hydrotherapy; Placebos [therapeutic use]; Randomized Controlled Trials as Topic; Transcutaneous Electric Nerve Stimulation [*methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012172.pub2&amp;doi=10.1002/14651858.CD012172.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="f00EizoA";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012172\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012172\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","ja","hr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012172.pub2",title:"Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults",firstPublishedDate:"Oct 9, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012172.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012172.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012172.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012172.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012172.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012172.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012172.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012172.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012172.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012172.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11037 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012172.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-sec-0125"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-sec-0029"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-sec-0030"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-sec-0055"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-sec-0119"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/appendices#CD012172-sec-0136"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information#CD012172-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Mark I Johnson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information#CD012172-cr-0003">Leica S Claydon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information#CD012172-cr-0004">G Peter Herbison</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information#CD012172-cr-0005">Gareth Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information#CD012172-cr-0006">Carole A Paley</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information/en#CD012172-sec-0141">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 October 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012172.pub2">https://doi.org/10.1002/14651858.CD012172.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012172-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012172-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012172-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012172-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012172-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012172-abs-0001" lang="en"> <section id="CD012172-sec-0001"> <h3 class="title" id="CD012172-sec-0001">Background</h3> <p>Fibromyalgia is characterised by persistent, widespread pain; sleep problems; and fatigue. Transcutaneous electrical nerve stimulation (TENS) is the delivery of pulsed electrical currents across the intact surface of the skin to stimulate peripheral nerves and is used extensively to manage painful conditions. TENS is inexpensive, safe, and can be self‐administered. TENS reduces pain during movement in some people so it may be a useful adjunct to assist participation in exercise and activities of daily living. To date, there has been only one systematic review in 2012 which included TENS, amongst other treatments, for fibromyalgia, and the authors concluded that TENS was not effective. </p> </section> <section id="CD012172-sec-0002"> <h3 class="title" id="CD012172-sec-0002">Objectives</h3> <p>To assess the analgesic efficacy and adverse events of TENS alone or added to usual care (including exercise) compared with placebo (sham) TENS; no treatment; exercise alone; or other treatment including medication, electroacupuncture, warmth therapy, or hydrotherapy for fibromyalgia in adults. </p> </section> <section id="CD012172-sec-0003"> <h3 class="title" id="CD012172-sec-0003">Search methods</h3> <p>We searched the following electronic databases up to 18 January 2017: CENTRAL (CRSO); MEDLINE (Ovid); Embase (Ovid); CINAHL (EBSCO); PsycINFO (Ovid); LILACS; PEDRO; Web of Science (ISI); AMED (Ovid); and SPORTDiscus (EBSCO). We also searched three trial registries. There were no language restrictions. </p> </section> <section id="CD012172-sec-0004"> <h3 class="title" id="CD012172-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) or quasi‐randomised trials of TENS treatment for pain associated with fibromyalgia in adults. We included cross‐over and parallel‐group trial designs. We included studies that evaluated TENS administered using non‐invasive techniques at intensities that produced perceptible TENS sensations during stimulation at either the site of pain or over nerve bundles proximal (or near) to the site of pain. We included TENS administered as a sole treatment or TENS in combination with other treatments, and TENS given as a single treatment or as a course of treatments. </p> </section> <section id="CD012172-sec-0005"> <h3 class="title" id="CD012172-sec-0005">Data collection and analysis</h3> <p>Two review authors independently determined study eligibility by assessing each record and reaching agreement by discussion. A third review author acted as arbiter. We did not anonymise the records of studies before assessment. Two review authors independently extracted data and assessed risk of bias of included studies before entering information into a 'Characteristics of included studies' table. Primary outcomes were participant‐reported pain relief from baseline of 30% or greater or 50% or greater, and Patient Global Impression of Change (PGIC). We assessed the evidence using GRADE and added 'Summary of findings' tables. </p> </section> <section id="CD012172-sec-0006"> <h3 class="title" id="CD012172-sec-0006">Main results</h3> <p>We included eight studies (seven RCTs, one quasi‐RCT, 315 adults (299 women), aged 18 to 75 years): six used a parallel‐group design and two used a cross‐over design. Sample sizes of intervention arms were five to 43 participants. </p> <p>Two studies, one of which was a cross‐over design, compared TENS with placebo TENS (82 participants), one study compared TENS with no treatment (43 participants), and four studies compared TENS with other treatments (medication (two studies, 74 participants), electroacupuncture (one study, 44 participants), superficial warmth (one cross‐over study, 32 participants), and hydrotherapy (one study, 10 participants)). Two studies compared TENS plus exercise with exercise alone (98 participants, 49 per treatment arm). None of the studies measured participant‐reported pain relief of 50% or greater or PGIC. Overall, the studies were at unclear or high risk of bias, and in particular all were at high risk of bias for sample size. </p> <p>Only one study (14 participants) measured the primary outcome participant‐reported pain relief of 30% or greater. Thirty percent achieved 30% or greater reduction in pain with TENS and exercise compared with 13% with exercise alone. One study found 10/28 participants reported pain relief of 25% or greater with TENS compared with 10/24 participants using superficial warmth (42 °C). We judged that statistical pooling was not possible because there were insufficient data and outcomes were not homogeneous. </p> <p>There were no data for the primary outcomes participant‐reported pain relief from baseline of 50% or greater and PGIC. </p> <p>There was a paucity of data for secondary outcomes. One pilot cross‐over study of 43 participants found that the mean (95% confidence intervals (CI)) decrease in pain intensity on movement (100‐mm visual analogue scale (VAS)) during one 30‐minute treatment was 11.1 mm (95% CI 5.9 to 16.3) for TENS and 2.3 mm (95% CI 2.4 to 7.7) for placebo TENS. There were no significant differences between TENS and placebo for pain at rest. One parallel group study of 39 participants found that mean ± standard deviation (SD) pain intensity (100‐mm VAS) decreased from 85 ± 20 mm at baseline to 43 ± 20 mm after one week of dual‐site TENS; decreased from 85 ± 10 mm at baseline to 60 ± 10 mm after single‐site TENS; and decreased from 82 ± 20 mm at baseline to 80 ± 20 mm after one week of placebo TENS. The authors of seven studies concluded that TENS relieved pain but the findings of single small studies are unlikely to be correct. </p> <p>One study found clinically important improvements in Fibromyalgia Impact Questionnaire (FIQ) subscales for work performance, fatigue, stiffness, anxiety, and depression for TENS with exercise compared with exercise alone. One study found no additional improvements in FIQ scores when TENS was added to the first three weeks of a 12‐week supervised exercise programme. </p> <p>No serious adverse events were reported in any of the studies although there were reports of TENS causing minor discomfort in a total of 3 participants. </p> <p>The quality of evidence was very low. We downgraded the GRADE rating mostly due to a lack of data; therefore, we have little confidence in the effect estimates where available. </p> </section> <section id="CD012172-sec-0007"> <h3 class="title" id="CD012172-sec-0007">Authors' conclusions</h3> <p>There was insufficient high‐quality evidence to support or refute the use of TENS for fibromyalgia. We found a small number of inadequately powered studies with incomplete reporting of methodologies and treatment interventions. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012172-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012172-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012172-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012172-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD012172-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012172-abs-0005">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012172-abs-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012172-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012172-abs-0003" lang="en"> <h3>TENS for fibromyalgia in adults</h3> <p><b>Review question</b> </p> <p>Does transcutaneous electrical nerve stimulation (TENS) relieve pain in adults with fibromyalgia? </p> <p><b>Background</b> </p> <p>Fibromyalgia is a long‐term medical condition that is characterised by long‐lasting widespread pain throughout the body. TENS is a treatment that involves putting pulsed electrical currents across the surface of the skin using two or four electrodes. It is used to manage painful conditions. TENS is inexpensive, can be self‐administered by people with fibromyalgia, and is not associated with any particular side effects. TENS reduces pain during movement so it may be useful in addition to other treatments to help people carry on their normal lives. </p> <p><b>Study characteristics</b> </p> <p>In January 2017, we found eight clinical studies that examined 315 people. We included TENS administered to produce a non‐painful 'tingling' sensation at the site of pain either as a treatment alone or combined with exercise treatment. All studies used TENS in comparison with 'fake' (called placebo or sham) TENS, no treatment, or other treatments such as medicine or hydrotherapy (treatment in water). </p> <p><b>Key results</b> </p> <p>We did not find enough high‐quality studies to allow us to come to any conclusions about the effectiveness of TENS for fibromyalgia pain. Even though seven studies concluded that TENS relieved pain associated with fibromyalgia, the studies were low quality and the findings for measures of pain were inconsistently reported. Studies did not measure most of our outcomes and it was not always clear what aspects of pain were being reported (e.g. present pain, remembered pain, pain severity, etc.). Only one small pilot study found that one 30‐minute treatment of TENS reduced pain on movement during and immediately after treatment; however, there were too few participants observed and it is unknown whether this effect would be maintained over a longer course of TENS treatments. Overall, it is not possible to judge whether TENS reduces pain associated with fibromyalgia. There were no serious side events reported in any of the studies. </p> <p><b>Quality of the evidence</b> <br/> We rated the quality of the evidence from studies using four levels: very low, low, moderate, or high. Very low‐quality evidence means that we are very uncertain about the results. High‐quality evidence means that we are very confident in the results. The quality of the evidence was very low overall because of a lack of data. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012172-sec-0125" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012172-sec-0125"></div> <h3 class="title" id="CD012172-sec-0126">Implications for practice</h3> <section id="CD012172-sec-0126"> <section id="CD012172-sec-0127"> <h5 class="title">For people with fibromyalgia</h5> <p>There is no high‐quality evidence to support or refute the use of transcutaneous electrical nerve stimulation (TENS for fibromyalgia. Further high‐quality research is needed before conclusions can be made about the efficacy and safety of TENS. </p> </section> <section id="CD012172-sec-0128"> <h5 class="title">For clinicians</h5> <p>Whether TENS should be considered as a potential treatment option for fibromyalgia remains a matter for debate. At present, there is insufficient evidence to support or refute the use of TENS for fibromyalgia. </p> </section> <section id="CD012172-sec-0129"> <h5 class="title">For policy‐makers</h5> <p>Our analysis of seven randomised controlled trials (RCTs) and one quasi‐RCT with 315 adults found insufficient evidence to support or refute the use of TENS for fibromyalgia. Studies had a high risk of bias associated with inadequate sample sizes in treatment arms and there was variability in study methodology and TENS dosage. </p> </section> <section id="CD012172-sec-0130"> <h5 class="title">For funders</h5> <p>The safety profile and ease of use of TENS compares favourably to alternative treatments because it can be self‐administered and is inexpensive and readily available without prescription. In some countries, TENS needs to be prescribed by a healthcare practitioner to claim reimbursement from social security or health insurance companies. </p> </section> </section> <h3 class="title" id="CD012172-sec-0131">Implications for research</h3> <section id="CD012172-sec-0131"> <section id="CD012172-sec-0132"> <h5 class="title">General</h5> <p>This review has identified the need for high‐quality research with long‐term follow‐up investigating the use of TENS for fibromyalgia pain. All the studies included in this review had design limitations such as inadequate sample sizes, outcome measures, and follow‐up. </p> </section> <section id="CD012172-sec-0133"> <h5 class="title">Design</h5> <p>As with previous Cochrane Reviews on TENS, we found a small number of inadequately powered studies with incomplete reporting of methodologies and treatment interventions. The CONSORT statement for non‐pharmacological treatments should be adopted to report all aspects of study design and subsequent reporting (<a href="./references#CD012172-bbs2-0026" title="BoutronI , MoherD , AltmanDG , SchulzKF , RavaudP , CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals Internal Medicine2008;148(4):295‐309. ">Boutron 2008</a>). A comprehensive review of TENS methodologies by <a href="./references#CD012172-bbs2-0021" title="BennettMI , HughesN , JohnsonMI . Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: low fidelity may explain negative findings. Pain2011;156(2):1226‐32. ">Bennett 2011</a> provides detailed criteria and operational guidelines to aid the design of future RCTs on TENS. Pain, Palliative and Supportive Care (PaPaS) guidance suggests that a sample size of 200 participants per treatment arm is necessary for a low risk of bias in RCTs so much larger sample sizes per treatment arms are needed in the future. The study by <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> included in this review has been used to inform the design of a phase II randomised, double‐blind, placebo‐controlled, multicentre clinical study that plans to recruit 360 participants with fibromyalgia and a protocol for this study has been published (<a href="./references#CD012172-bbs2-0015" title="NoehrenB , DaileyDL , RakelBA , VanceCG , ZimmermanMB , CroffordLJ , et al. Effect of transcutaneous electrical nerve stimulation on pain, function, and quality of life in fibromyalgia: a double‐blind randomized clinical trial. Physical Therapy2015;95(1):129‐40. ">Noehren 2015</a>). It is expected that the findings will be available in a future update of this review. For meta‐analyses, the PaPaS template protocol for the evaluation of drugs for neuropathic pain recommends that at least 500 participants would be needed to measure the magnitude of a treatment effect adequately for comparisons in which the number needed to treat for an additional beneficial outcome (NNTB) is four or above (<a href="./references#CD012172-bbs2-0079" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. ">Moore 1998</a>). </p> <p>To assess the effects of TENS on chronic pain long‐term studies of a minimum of six weeks, but ideally more than six months, are necessary to monitor the decline in people who continue to use TENS long term. Ideally, TENS should be self‐administered at home with people using TENS regularly throughout the day whenever they are in pain and for at least 30 minutes at a time whenever possible. In such studies, barriers to effective long‐term TENS use should be evaluated and resolved before the start of the TENS intervention. <a href="./references#CD012172-bbs2-0047" title="GladwellPW , BadlanK , CrampF , PalmerS . Problems, solutions, and strategies reported by users of transcutaneous electrical nerve stimulation for chronic musculoskeletal pain: qualitative exploration using patient interviews. Physical Therapy2015;96(7):1039‐48. ">Gladwell 2015a</a> suggested that a learning phase should be incorporated into future studies to allow people to maximise the complex pattern of TENS usage. This could be achieved during a 'run‐in' period in an enriched enrolment randomised withdrawal design whereby all participants initially receive active TENS to titrate dosage and optimise TENS technique (<a href="./references#CD012172-bbs2-0093" title="MooreRA , DerryS , WiffenPJ . Challenges in design and interpretation of chronic pain trials. British Journal of Anaesthesia2013;111(1):38‐45. ">Moore 2013c</a>). Participants who do not achieve benefits or experience adverse events (or both) are withdrawn from the study and the remaining participants randomised to receive active or placebo TENS to determine efficacy. Blinding of participants to active and placebo TENS becomes a challenge in such a design because participants become aware of sensations generated by TENS in the run‐in phase. However, electrotherapeutic devices that do not produce sensations during stimulation are available (e.g. microcurrent) and information about them can be used in briefing information to create uncertainty about the need for TENS sensation for beneficial effects (see <a href="./references#CD012172-bbs2-0062" title="JohnsonMI . Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014. ">Johnson 2014</a>, p. 170) This, coupled with the use of credible sham (no current) TENS devices, can effectively blind participants (<a href="./references#CD012172-bbs2-0104" title="RakelB , CooperN , AdamsHJ , MesserBR , Frey LawLA , DannenDR , et al. A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment. Journal of Pain2010;11(3):230‐8. ">Rakel 2010</a>). Blinding can be monitored post‐intervention using simple questions such as 'do you believe your TENS device was functioning properly?' (<a href="./references#CD012172-bbs2-0040" title="DeyoR , WalshN , SchoenfeldL , RamamurthyS . Can trials of physical treatments be blinded? The example of transcutaneous electrical nerve stimulation for chronic pain. American Journal of Physical Medicine and Rehabilitation1990;69(1):6‐10. ">Deyo 1990</a>). Monitoring TENS usage in home studies can be achieved using electronic monitoring devices to assure participant compliance with the recommended TENS treatment protocol and TENS usage can also be used as an outcome measure (<a href="./references#CD012172-bbs2-0100" title="PallettEJ , RentowlP , JohnsonMI , WatsonPJ . Implementation fidelity of self‐administered transcutaneous electrical nerve stimulation (TENS) in patients with chronic back pain: an observational study. Clinical Journal of Pain2014;30:224‐31. ">Pallett 2014</a>). </p> <p>To ensure high‐quality evidence in future studies ‐ in addition to having an adequate sample size, adequate dose, and a credible sham device ‐ researchers should consider measuring pain both during use of TENS and afterwards and also monitoring ongoing use of TENS. A health economic assessment would also be useful to enable a cost‐benefit analysis to be produced. </p> </section> <section id="CD012172-sec-0134"> <h5 class="title">Measurement</h5> <p>Future studies should use pain outcomes recommended by IMMPACT. The primary outcome should be the number of participants reporting at least a 30% or 50% reduction in pain intensity while TENS is switched on. Concurrent analgesia should be standardised and monitored. However, evaluating TENS using a unidimensional pain scale is likely to overlook other potential benefits such as 'distraction from pain,' alleviation of other unpleasant sensations (e.g. muscle tension or spasm), reduction in medication consumption, and improvements in function (<a href="./references#CD012172-bbs2-0048" title="GladwellPW , BadlanK , CrampF , PalmerS . Direct and indirect benefits reported by users of transcutaneous electrical nerve stimulation for chronic musculoskeletal pain: qualitative exploration using patient interviews. Physical Therapy2015;92(11):1518‐28. ">Gladwell 2015b</a>). These should be considered important secondary outcomes. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012172-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012172-sec-0022"></div> <div class="table" id="CD012172-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">TENS compared to placebo TENS for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>TENS compared to placebo TENS for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with fibromyalgia </p> <p><b>Setting:</b> hospital and university clinic </p> <p><b>Intervention:</b> TENS </p> <p><b>Comparison:</b> placebo TENS </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Probable outcome with TENS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Probable outcome with placebo TENS</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 30%</b> (≥ 30% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 50%</b> (≥ 50% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC much or very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>In a cross‐over study, <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported 2 withdrawals after the no‐TENS intervention (without reasons) resulting in missing data from the TENS and placebo TENS interventions. <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> reported 2 withdrawals from the placebo TENS group and 1 withdrawal from the TENS group due to absence of symptom relief. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54 participants per treatment arm</p> <p>(2 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>PGIC:</b> Patient Global Impression of Change; <b>RCT:</b> randomised controlled trial; <b>TENS:</b> transcutaneous electrical nerve stimulation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD012172-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">TENS compared to no treatment for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>TENS compared to no treatment for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with fibromyalgia </p> <p><b>Setting:</b> university clinic </p> <p><b>Intervention:</b> TENS </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probably outcome with TENS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Probable outcome with no treatment </b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 30%</b> (≥ 30% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 50%</b> (≥ 50% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC much or very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>In a cross‐over study, <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported that there were 2 withdrawals after the no‐TENS intervention (without reasons) resulting in missing data from the TENS and placebo TENS interventions. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>PGIC:</b> Patient Global Impression of Change; <b>RCT:</b> randomised controlled trial; <b>TENS:</b> transcutaneous electrical nerve stimulation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD012172-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">TENS with exercise compared to exercise alone for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>TENS with exercise compared to exercise alone for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with fibromyalgia </p> <p><b>Setting:</b> hospital and university clinic </p> <p><b>Intervention:</b> TENS with exercise </p> <p><b>Comparison:</b> exercise on its own </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probably outcome with TENS with exercise</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Probable outcome with exercise on its own</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 30%</b> (≥ 30% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> reported that 30% of 14 participants in the TENS with exercise group achieved ≥ 30% reduction in pain and this was significantly greater than 13% of 14 participants in the exercise without TENS group. However, these percentages equate to 4.2 participants and 1.82 participants respectively, which is illogical. The mean ± SD reduction in pain intensity was 20 ± 29 mm for TENS and 7.0 ± 3 7 mm for the exercise without TENS. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 50%</b> (≥ 50% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b>LOW </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC much or very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> reported 2 withdrawals and 2 dropouts in equal numbers from each group with no reasons. <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a> reported 3 withdrawals from the exercise alone group and 3 withdrawals from the exercise with TENS groups stating that there were similar reasons for the withdrawals, although further details were not provided. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>PGIC:</b> Patient Global Impression of Change; <b>RCT:</b> randomised controlled trial; <b>SD:</b> standard deviation; <b>TENS:</b> transcutaneous electrical nerve stimulation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD012172-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">TENS compared to other active treatment for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>TENS compared to another treatment for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with fibromyalgia<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> TENS<br/> <b>Comparison:</b> another treatment (e.g. superficial warmth, hydrotherapy, electroacupuncture, medication) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probably outcome with TENS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probably outcome with another treatment</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 30%</b> (≥ 30% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> reported that post‐TENS 10/28 participants analysed achieved a decrease in pain severity of ≥ 20 units on a 100‐unit NRS (i.e. pain relief of 25%) compared with 10/24 participants in the superficial warmth (42 °C) group with no statistically significant differences between the groups. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 50%</b> (≥ 50% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC much or very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> reported that 2 participants reported increased pain during TENS. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NRS:</b> numerical rating scale; <b>PGIC:</b> Patient Global Impression of Change; <b>TENS:</b> transcutaneous electrical nerve stimulation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012172-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012172-sec-0023"></div> <p>This review is based on a template for reviews of drugs used to relieve fibromyalgia. The aim is for all reviews to use the same methods, based on new criteria for what constitutes reliable evidence in chronic pain (<a href="./references#CD012172-bbs2-0082" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>; <a href="./appendices#CD012172-sec-0137">Appendix 1</a>). </p> <section id="CD012172-sec-0024"> <h3 class="title" id="CD012172-sec-0024">Description of the condition</h3> <p>Fibromyalgia is a long‐term medical condition that is characterised by chronic widespread pain in the muscles and joints, with sensitivity to pressure stimuli. The symptoms may vary from person to person, but the main symptom is widespread pain throughout the body. This may be worse in certain areas, such as the back or neck. Pain may be described as aching, burning, stabbing, or sharp and may be accompanied by hyperalgesia (heightened sensitivity to pain) and allodynia (pain on very mild stimulus). Pain is often continuous but it may fluctuate in severity depending on various factors including stress, physical activity, and the weather. Exposure to certain environmental stimuli (e.g. smoke, certain foods, and bright lights) may cause flare‐ups. Other presenting symptoms may include stiffness, especially in the morning; muscle spasm; depression; fatigue; poor sleep quality, including non‐restorative sleep; cognitive difficulties in thinking, learning, attention, and concentration; headaches, including severe migraines; and irritable bowel syndrome (<a href="./references#CD012172-bbs2-0127" title="WolfeF , WalittBT , HauserW . What is fibromyalgia, how is it diagnosed and what does it really mean?. Arthritis Care and Research2014;66(7):969‐71. ">Wolfe 2014</a>). Originally, the American College of Rheumatology classification criteria for fibromyalgia were widespread pain (axial pain, left‐ and right‐sided pain, upper and lower segment pain) that lasts for longer than three months, with pain on palpation at 11 or more of 18 specified tender points (<a href="./references#CD012172-bbs2-0124" title="WolfeF , SymtheHA , YunusMB , BennettRM , BombardierC , GoldenbergDL , et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism1990;33:160‐72. ">Wolfe 1990</a>). More recently, a definition of fibromyalgia has been proposed based on symptom severity and the presence of widespread pain, which does not require palpation of tender points for diagnosis (<a href="./references#CD012172-bbs2-0125" title="WolfeF , ClauwDJ , FitzcharlesMA , ColdenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research2010;62:600‐10. ">Wolfe 2010</a>). Thus, fibromyalgia is diagnosed if the person has: a widespread pain index (WPI) of 7 or greater and a symptom severity scale score of 5 or greater, or a WPI of between 3 and 6 and a symptom severity scale score of 9 or greater; symptoms have persisted at a similar level for three months or greater; and the pain cannot be explained by another disorder. </p> <p>While some rheumatologists have thought of fibromyalgia as a specific pain disorder, other investigators have characterised it as a bodily distress syndrome or a physical symptom disorder, or somatoform disorder (<a href="./references#CD012172-bbs2-0127" title="WolfeF , WalittBT , HauserW . What is fibromyalgia, how is it diagnosed and what does it really mean?. Arthritis Care and Research2014;66(7):969‐71. ">Wolfe 2014</a>). It is a heterogeneous condition in which there is abnormal processing of the sensation of pain. The cause, or causes, are not well understood, but it has features in common with neuropathic pain, including changes in the central nervous system (CNS). Moreover, people with neuropathic pain and some people with fibromyalgia experience similar sensory phenomena (<a href="./references#CD012172-bbs2-0068" title="KoroschetzJ , RehmSE , GockelU , BroszM , FreynhagenR , TolleTR , et al. Fibromyalgia and neuropathic pain ‐ differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurology2011;11:55. ">Koroschetz 2011</a>). Many people with fibromyalgia are significantly disabled, and experience moderate or severe pain for many years. Chronic painful conditions comprised five of the 11 top‐ranking conditions for years lived with disability in 2010 (<a href="./references#CD012172-bbs2-0119" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990‐2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380:2163‐96. ">Vos 2012</a>), and are responsible for considerable loss of quality of life and employment, and increased health costs (<a href="./references#CD012172-bbs2-0094" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2014;14(1):79‐94. ">Moore 2014a</a>). </p> <p>Fibromyalgia is common. Numerous studies have investigated prevalence in different settings and countries. The review by <a href="./references#CD012172-bbs2-0103" title="QueirozLP . Worldwide epidemiology of fibromyalgia. Current Pain and Headache Reports2013;17(8):356. ">Queiroz 2013</a> gave a global mean prevalence of 2.7% (range 0.4% to 9.3%), and a mean in the Americas of 3.1%, in Europe of 2.5%, and in Asia of 1.7%. Fibromyalgia is more common in women, with a female to male ratio of 3:1 (4.2%:1.4%). The change in diagnostic criteria does not appear to have significantly affected estimates of prevalence (<a href="./references#CD012172-bbs2-0126" title="WolfeF , BrahlerE , HinzA , HauserW . Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis and Research Care2013;645(5):777‐85. ">Wolfe 2013</a>). Estimates of prevalence in specific populations vary greatly, but have been reported to be as high as 9% in female textile workers in Turkey and 10% in metalworkers in Brazil (59% in those with repetitive strain injury; <a href="./references#CD012172-bbs2-0103" title="QueirozLP . Worldwide epidemiology of fibromyalgia. Current Pain and Headache Reports2013;17(8):356. ">Queiroz 2013</a>). Risk factors for fibromyalgia include: sex (it is more common in women than in men); family history (it is more likely if a relative has the condition); age (it is more common as age increases); and rheumatic disease (rheumatoid arthritis or lupus) (<a href="./references#CD012172-bbs2-0126" title="WolfeF , BrahlerE , HinzA , HauserW . Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis and Research Care2013;645(5):777‐85. ">Wolfe 2013</a>). The financial burden of fibromyalgia on society is significant. One cross‐sectional study on 299 people with fibromyalgia in France and Germany estimated that, on average, people visited their physician 11.6 (France) and 19.6 (Germany) times per year and missed 32.4 (France) and 25.2 (Germany) days of work per year (<a href="./references#CD012172-bbs2-0123" title="WinklemannA , PerrotS , SchaeferC , RyanK , ChandranA , SadoskyA , et al. Impact of fibromyalgia severity on health economic costs: results from a European cross‐sectional study. Applied Health Economics and Health Policy2011;9:125‐36. ">Winklemann 2011</a>). Total annual costs to society based on three‐month data from 2008 were EUR 7900 in France and EUR 7256 in Germany per person. Direct costs from physician clinic visits, medications, and out‐of‐pocket expenses were EUR 910 (France) and EUR 1765 (Germany), and indirect costs from missed days of work and lost productivity were EUR 6990 (France) and EUR 5491 (Germany). </p> <p>There are no definitive treatments for fibromyalgia. Fibromyalgia pain is difficult to treat effectively, with only a minority of people experiencing a clinically relevant benefit from any one intervention. A multidisciplinary approach is now advocated, with pharmacological interventions being combined with physical or cognitive interventions, or both. Conventional analgesics are usually not effective. Treatment is often by so‐called unconventional analgesics, such as antidepressants such as duloxetine and amitriptyline (<a href="./references#CD012172-bbs2-0073" title="LunnMP , HughesRA , WiffenPJ . Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD007115.pub3] ">Lunn 2014</a>; <a href="./references#CD012172-bbs2-0089" title="MooreRA , DerryS , AldingtonD , ColeP , WiffenPJ . Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD008242.pub2] ">Moore 2012a</a>; <a href="./references#CD012172-bbs2-0117" title="SultanA , GaskellH , DerryS , MooreRA . Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology2008;8:29. ">Sultan 2008</a>), or antiepileptic drugs such as gabapentin or pregabalin (<a href="./references#CD012172-bbs2-0081" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009</a>; <a href="./references#CD012172-bbs2-0086" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub3] ">Moore 2011a</a>; <a href="./references#CD012172-bbs2-0120" title="WiffenPJ , DerryS , MooreRA , AldingtonD , ColeP , RiceASC . Antiepileptic drugs for neuropathic pain and fibromyalgia ‐ an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD010567.pub2] ">Wiffen 2013</a>). The proportion of people who achieve worthwhile pain relief (typically at least a 50% reduction in pain intensity; <a href="./references#CD012172-bbs2-0091" title="MooreA , DerryS , EcclestonC , KalsoE . Expect analgesic failure: pursue analgesic success. BMJ2013;346:f2690. ">Moore 2013a</a>) is small, generally only 10% to 25% more than with placebo, with numbers needed to treat for an additional beneficial outcome (NNTB) usually between four and 10 (<a href="./references#CD012172-bbs2-0120" title="WiffenPJ , DerryS , MooreRA , AldingtonD , ColeP , RiceASC . Antiepileptic drugs for neuropathic pain and fibromyalgia ‐ an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD010567.pub2] ">Wiffen 2013</a>). People who do experience good levels of pain relief, however, also benefit from substantial reductions in other symptoms, such as fatigue, function, sleep, depression, anxiety, and ability to work, with significant improvement in quality of life (<a href="./references#CD012172-bbs2-0083" title="MooreRA , StraubeS , PaineJ , PhillipsCJ , DerryS , McQuayHJ . Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain2010;149(2):360‐4. [DOI: 10.1016/j.pain.2010.02.039] ">Moore 2010b</a>; <a href="./references#CD012172-bbs2-0094" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2014;14(1):79‐94. ">Moore 2014a</a>; <a href="./references#CD012172-bbs2-0116" title="StraubeS , MooreRA , PaineJ , DerryS , PhillipsCJ , HallierE , et al. Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response. BMC Musculoskeletal Disorders2011;12:125. ">Straube 2011</a>). Fibromyalgia is not particularly different from other chronic pain in that only a small proportion of study participants have a good response to treatment (<a href="./references#CD012172-bbs2-0091" title="MooreA , DerryS , EcclestonC , KalsoE . Expect analgesic failure: pursue analgesic success. BMJ2013;346:f2690. ">Moore 2013a</a>). </p> </section> <section id="CD012172-sec-0025"> <h3 class="title" id="CD012172-sec-0025">Description of the intervention</h3> <p>Transcutaneous electrical nerve stimulation (TENS) is the delivery of pulsed electrical currents across the intact surface of the skin to stimulate peripheral nerves, principally for pain relief (<a href="./references#CD012172-bbs2-0018" title="American Physical Therapy Association. Guide to physical therapist practice. Physical Therapy. 2nd Edition. Vol. 81, Alexandria (VA): American Physical Therapy Association, 2001. ">APTA 2001</a>; <a href="./references#CD012172-bbs2-0062" title="JohnsonMI . Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014. ">Johnson 2014</a>). TENS treatment is usually self‐administered, ideally following instruction from a healthcare practitioner. A portable, battery‐powered TENS device is used to produce the electrical currents and these are delivered to the body using self‐adhering electrodes attached to the surface of the skin. TENS is inexpensive, with a good safety profile compared with medication. TENS devices and accessories (lead wires and self‐adhering electrodes) are available without prescription. In some countries TENS needs to be prescribed by a healthcare practitioner to claim reimbursement from social security or health insurance companies. Professional bodies published robust safety guidelines to guide judgements about the appropriateness of TENS in certain situations (<a href="./references#CD012172-bbs2-0055" title="HoughtonP , NussbaumE , HoensA . Electrophysical agents ‐ contraindications and precautions: an evidence‐based approach to clinical decision making in physical therapy. Physiotherapy Canada2010;62(5):1‐80. ">Houghton 2010</a>). Contraindications include people who have cardiac pacemakers and implantable cardioverter defibrillators. Precautions include pregnancy, epilepsy, active malignancy, deep‐vein thrombosis, and frail or damaged skin (<a href="./references#CD012172-bbs2-0061" title="JohnsonMI , BjordalJM . Transcutaneous electrical nerve stimulation for the management of painful conditions: focus on neuropathic pain. Expert Review of Neurotherapeutics2011;11(5):735‐53. ">Johnson 2011</a>). </p> <p>TENS devices create pulsed currents with asymmetrical biphasic rectangular or symmetrical biphasic rectangular waveforms. TENS devices are designed so that users can adjust the electrical characteristics of the currents including: pulse frequency (usually less than 200 Hz), pulse amplitude (usually less than 70 mA), pulse duration (usually 50 μseconds to 250 μseconds), and pulse pattern (sometimes termed 'mode' and including continuous, burst, and modulated). Modulated pulse patterns may help to reduce tolerance to TENS caused by repeated use and include modulated frequency, modulated amplitude, and modulated duration (<a href="./references#CD012172-bbs2-0112" title="SlukaKA , BjordalJM , MarchandS , RakelBA . What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Physical Therapy2013;93(10):1397‐402. ">Sluka 2013</a>). </p> <p>The International Association for the Study of Pain defined two TENS techniques which are commonly used in the literature (<a href="./references#CD012172-bbs2-0030" title="CharltonJ . Stimulation‐produced analgesia. In: CharltonJ editor(s). Task Force on Professional Education. Washington (DC): IASP Press, 2005:93‐6. ">Charlton 2005</a>): conventional TENS administered using high‐frequency, low‐intensity currents to produce a strong non‐painful TENS sensation; and acupuncture‐like TENS (AL‐TENS) using low‐frequency, high‐intensity currents to produce strong non‐painful pulsate sensations, phasic muscle contractions (twitching), or both (<a href="./references#CD012172-bbs2-0034" title="ClaydonLS , ChestertonLS . Does transcutaneous electrical nerve stimulation (TENS) produce 'dose' responses? A review of systematic reviews on chronic pain. Physical Therapy Reviews2008;13(6):450‐63. ">Claydon 2008a</a>). Low‐frequency TENS is consistently defined as the delivery of pulsed current of 10 Hz or less or low‐frequency trains (bursts) of high‐frequency pulsed current (i.e. burst mode TENS). High‐frequency TENS is often described as pulsed current between about 50 Hz and 100 Hz, although this neglects frequencies between 11 Hz and 49 Hz and frequencies above 100 Hz. The term medium‐frequency TENS is rarely used in the literature so high‐frequency TENS should be used to describe frequencies greater than 10 Hz to the maximum setting on the TENS device, which is usually 150 Hz to 200 Hz (<a href="./references#CD012172-bbs2-0062" title="JohnsonMI . Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014. ">Johnson 2014</a>). High‐frequency TENS is not always applied at a low intensity and low‐frequency TENS is not always applied at a high intensity. Low‐frequency TENS applied 10% below motor threshold generates analgesia in humans and reduces primary and secondary joint inflammation in animal models of nociception (<a href="./references#CD012172-bbs2-0031" title="ChenCC , TabasamG , JohnsonMI . Does the pulse frequency of transcutaneous electrical nerve stimulation (TENS) influence hypoalgesia? A systematic review of studies using experimental pain and healthy human participants. Physiotherapy2008;94(1):11‐20. ">Chen 2008</a>; <a href="./references#CD012172-bbs2-0067" title="KingEW , SlukaKA . The effect of varying frequency and intensity of transcutaneous electrical nerve stimulation on secondary mechanical hyperalgesia in an animal model of inflammation. Journal of Pain2001;2:128‐33. ">King 2001</a>; <a href="./references#CD012172-bbs2-0108" title="SlukaKA , BaileyK , BogushJ , OlsonR , RickettsA . Treatment with either high or low frequency TENS reduces the secondary hyperalgesia observed after injection of kaolin and carrageenan into the knee joint. Pain1998;77:97‐102. ">Sluka 1998</a>; <a href="./references#CD012172-bbs2-0112" title="SlukaKA , BjordalJM , MarchandS , RakelBA . What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Physical Therapy2013;93(10):1397‐402. ">Sluka 2013</a>; <a href="./references#CD012172-bbs2-0118" title="VanceCG , RadhakrishnanR , SkybaDA , SlukaKA . Transcutaneous electrical nerve stimulation at both high and low frequencies reduces primary hyperalgesia in rats with joint inflammation in a time‐dependent manner. Physical Therapy2007;87(1):44‐51. ">Vance 2007</a>). The critical factor for response to TENS is the perceptual experience of the intensity of currents during stimulation regardless of frequency. Evidence suggests that optimal hypoalgesia is achieved using pulse amplitudes (mA) that generate a strong, non‐painful TENS sensation and therefore pulse amplitude should be titrated during treatment to maintain this intensity level (<a href="./references#CD012172-bbs2-0024" title="BjordalJM , JohnsonMI , LjunggreenAE . Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta‐analysis with assessment of optimal treatment parameters for postoperative pain. European Journal of Pain2003;7:181‐8. ">Bjordal 2003</a>; <a href="./references#CD012172-bbs2-0096" title="MoranF , LeonardT , HawthorneS , HughesCM , McCrum‐GardnerE , JohnsonMI , et al. Hypoalgesia in response to transcutaneous electrical nerve stimulation (TENS) depends on stimulation intensity. Journal of Pain2011;12(8):929‐35. ">Moran 2011</a>; <a href="./references#CD012172-bbs2-0112" title="SlukaKA , BjordalJM , MarchandS , RakelBA . What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Physical Therapy2013;93(10):1397‐402. ">Sluka 2013</a>). Thus, we intended to undertake a subgroup analysis of intensity ('strong' versus 'barely perceptible'), frequency (low frequency versus high frequency when intensity is 'strong'), and technique (conventional TENS versus AL‐TENS), if sufficient data were available. </p> <p>Response to TENS is also influenced by site of stimulation according to the placement of electrodes. Best practice guidelines suggest that electrodes should be placed on healthy sensate skin so that the TENS sensation covers (permeates) the painful area. This is achieved by placing electrodes directly over or 'bracketing' the painful site. This may not always be possible because, for example, skin sensation is altered, there is a skin lesion, or a body part is absent. In these circumstances, electrodes are placed over the main nerves proximal to the site of pain, close to vertebrae of spinal segments, over contralateral dermatomes, over acupuncture points (acu‐TENS), or over myofascial trigger points. Research findings on the effect of the site of stimulation on treatment outcome are ambiguous (<a href="./references#CD012172-bbs2-0062" title="JohnsonMI . Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014. ">Johnson 2014</a>). Consideration also needs to be given to the duration and regularity of treatment and the timing of outcome measurements. In particular, evidence suggests that the effects of TENS are maximal during stimulation or immediately after stimulation (<a href="./references#CD012172-bbs2-0112" title="SlukaKA , BjordalJM , MarchandS , RakelBA . What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Physical Therapy2013;93(10):1397‐402. ">Sluka 2013</a>), and that some studies have failed to measure outcome during stimulation (<a href="./references#CD012172-bbs2-0021" title="BennettMI , HughesN , JohnsonMI . Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: low fidelity may explain negative findings. Pain2011;156(2):1226‐32. ">Bennett 2011</a>; <a href="./references#CD012172-bbs2-0024" title="BjordalJM , JohnsonMI , LjunggreenAE . Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta‐analysis with assessment of optimal treatment parameters for postoperative pain. European Journal of Pain2003;7:181‐8. ">Bjordal 2003</a>). Thus, we intended to undertake a subgroup analysis of during TENS versus after TENS if sufficient data were available. </p> </section> <section id="CD012172-sec-0026"> <h3 class="title" id="CD012172-sec-0026">How the intervention might work</h3> <p>The theoretical underpinning for pain relief by electrical stimulation of the skin was established through the publication of the Gate Control Theory of Pain by Melzack and Wall (<a href="./references#CD012172-bbs2-0077" title="MelzackR , WallPD . Pain mechanisms: a new theory. Science1965;150(3699):971‐9. ">Melzack 1965</a>). They proposed that neural activity in low‐threshold cutaneous afferents (e.g. A‐beta axons) would inhibit onward transmission of nociceptive (pain‐related) information in the spinal cord and brainstem. Normally, activity in low‐threshold cutaneous afferents is generated by low‐intensity mechanical stimuli such as 'rubbing the skin.' They suggested that electrical currents could be used to stimulate the low‐threshold cutaneous afferents to reduce pain. The physiological intention of using conventional TENS is to generate a strong but non‐painful TENS sensation as this is indicative of selective activation of low‐threshold cutaneous afferents (A‐beta axons). Evidence suggests that this inhibits onward transmission of nociceptive information at the first synapse in the spinal cord or brain stem (i.e. segmental modulation; <a href="./references#CD012172-bbs2-0045" title="GarrisonDW , ForemanRD . Effects of transcutaneous electrical nerve stimulation (TENS) on spontaneous and noxiously evoked dorsal horn activity in cats with transected spinal cords. Neuroscience Letters1996;216(2):125‐8. ">Garrison 1996</a>; <a href="./references#CD012172-bbs2-0074" title="MaYT , SlukaKA . Reduction in inflammation‐induced sensitization of dorsal horn neurons by transcutaneous electrical nerve stimulation in anesthetized rats. Experimental Brain Research2001;137(1):94‐102. ">Ma 2001</a>). The intention of using AL‐TENS is to generate pulsate sensations in the skin and underlying tissue or non‐painful muscle twitching (or both) as this produces neural activity in small diameter muscle afferents leading to activation of descending pain inhibitory pathways (<a href="./references#CD012172-bbs2-0039" title="DeSantanaJM , daSilvaLF , deResendeMA , SlukaKA . Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience2009;163(4):1233‐41. ">DeSantana 2009</a>; <a href="./references#CD012172-bbs2-0043" title="FrancisRP , JohnsonMI . The characteristics of acupuncture‐like transcutaneous electrical nerve stimulation (acupuncture‐like TENS): a literature review. Acupuncture &amp; Electro‐Therapeutics Research2011;36(3/4):231‐58. ">Francis 2011</a>; <a href="./references#CD012172-bbs2-0065" title="KalraA , UrbanO , SlukaKA . Blockade of opioid receptors in rostral ventral medulla prevents anti‐hyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). Journal of Pharmacological and Experimental Therapeutics2001;298(1):257‐63. ">Kalra 2001</a>; <a href="./references#CD012172-bbs2-0078" title="MillanMJ . Descending control of pain. Progress in Neurobiology2002;66(6):355‐474. ">Millan 2002</a>). TENS may also reduce nociceptive input to the CNS by blocking incoming afferent activity in peripheral neurons, creating a 'busy‐line' effect (<a href="./references#CD012172-bbs2-0097" title="NardoneA , SchieppatiM . Influences of transcutaneous electrical stimulation of cutaneous and mixed nerves on subcortical and cortical somatosensory evoked potentials. Electroencephalography and Clinical Neurophysiology1989;74(1):24‐35. ">Nardone 1989</a>). </p> <p>Research on animals suggests that low‐frequency TENS, when administered just below motor threshold, mediates effects via noradrenaline, serotonin, and μ‐opioid systems and high‐frequency TENS, when administered just below motor threshold, mediates effects via noradrenaline, gamma‐aminobutyric acid (GABA), and δ‐opioid systems (<a href="./references#CD012172-bbs2-0065" title="KalraA , UrbanO , SlukaKA . Blockade of opioid receptors in rostral ventral medulla prevents anti‐hyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). Journal of Pharmacological and Experimental Therapeutics2001;298(1):257‐63. ">Kalra 2001</a>; <a href="./references#CD012172-bbs2-0070" title="LeonardG , GoffauxP , MarchandS . Deciphering the role of endogenous opioids in high‐frequency TENS using low and high doses of naloxone. Pain2010;151(1):215‐9. ">Leonard 2010</a>; <a href="./references#CD012172-bbs2-0076" title="MaedaY , LisiTL , VanceCG , SlukaKA . Release of GABA and activation of GABA(a) in the spinal cord mediates the effects of TENS. Brain Research2007;1136(1):43‐50. ">Maeda 2007</a>; <a href="./references#CD012172-bbs2-0107" title="SantosCM , FransischiJN , Lima‐PaivaP , SlukaKA , ResendeMA . Effect of transcutaneous electrical stimulation on nociception and edema produced by peripheral serotonin. International Journal of Neuroscience2013;123(7):507‐15. ">Santos 2013</a>; <a href="./references#CD012172-bbs2-0109" title="SlukaKA , DeaconM , StibalA , StisselS , TerpstraA . Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. Journal of Pharmacological and Experimental Therapeutics1999;289(2):280‐6. ">Sluka 1999</a>; <a href="./references#CD012172-bbs2-0111" title="SlukaKA , LisiTL , WestlundKN . Increased release of serotonin in the spinal cord during low, but not high, frequency transcutaneous electrical nerve stimulation in rats with joint inflammation. Archives of Physical Medicine and Rehabilitation2006;87(8):1137‐40. ">Sluka 2006</a>; <a href="./references#CD012172-bbs2-0113" title="SomersDL , ClementeFR . Contralateral high or a combination of high‐and‐low frequency transcutaneous electrical nerve stimulation reduces mechanical allodynia and alters dorsal horn neurotransmitter content in neuropathic rats. Journal of Pain2009;10(2):221‐9. ">Somers 2009</a>). Whether the frequency‐mediated effects of TENS translate into differential hypoalgesia in humans when the intensity of TENS is kept constant remains in doubt (<a href="./references#CD012172-bbs2-0031" title="ChenCC , TabasamG , JohnsonMI . Does the pulse frequency of transcutaneous electrical nerve stimulation (TENS) influence hypoalgesia? A systematic review of studies using experimental pain and healthy human participants. Physiotherapy2008;94(1):11‐20. ">Chen 2008</a>; <a href="./references#CD012172-bbs2-0034" title="ClaydonLS , ChestertonLS . Does transcutaneous electrical nerve stimulation (TENS) produce 'dose' responses? A review of systematic reviews on chronic pain. Physical Therapy Reviews2008;13(6):450‐63. ">Claydon 2008a</a>). There is evidence that long‐term use of opioid medication may impact negatively on response to low‐frequency TENS but not on response to high‐frequency TENS (<a href="./references#CD012172-bbs2-0110" title="SlukaKA , JudgeMA , McCoolleyMM , ReveizPM , TaylorBM . Low frequency TENS is less effective than high frequency TENS at reducing inflammation‐induced hyperalgesia in morphine‐tolerant rats. European Journal of Pain2000;4:185‐93. ">Sluka 2000</a>). <a href="./references#CD012172-bbs2-0071" title="LeonardG , CloutierC , MarchandS . Reduced analgesic effect of acupuncture‐like TENS but not conventional TENS in opioid‐treated patients. Journal of Pain2011;12:213‐21. ">Leonard 2011</a> found that high‐frequency TENS reduced pain in 12 opioid‐treated people with chronic pain and 11 opioid‐naïve people with chronic pain, whereas low‐frequency TENS only reduced pain in the non‐opioid group. The lack of pain relief during low‐frequency TENS was attributed to the development of μ‐opioid receptor tolerance. </p> <section id="CD012172-sec-0027"> <h4 class="title">Sham credibility issues in studies of transcutaneous electrical nerve stimulation</h4> <p><a href="./references#CD012172-bbs2-0021" title="BennettMI , HughesN , JohnsonMI . Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: low fidelity may explain negative findings. Pain2011;156(2):1226‐32. ">Bennett 2011</a> examined aspects of fidelity that may contribute to a risk of bias in TENS studies. Factors that contributed to the overestimation of TENS effects included inadequate method of randomisation, small sample sizes, and issues associated with the implementation of a sham (placebo) control such as allocation concealment and how blinding was maintained. Various types of sham control have been used in TENS studies, including deactivated TENS devices that are identical in appearance but deliver no current and TENS devices that deliver stimulation at the start of treatment and fade to zero current output over a brief period of time (e.g. within 45 seconds) (<a href="./references#CD012172-bbs2-0104" title="RakelB , CooperN , AdamsHJ , MesserBR , Frey LawLA , DannenDR , et al. A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment. Journal of Pain2010;11(3):230‐8. ">Rakel 2010</a>). There are threats to the credibility of this approach because active stimulation elicits sensations and introduces a risk of bias to sham‐controlled interventions. Thus, it is not possible to truly blind the person to the sensory experience generated by different types of TENS or the lack of sensation during sham (no current) TENS (or both). However, the nature of the TENS intervention can be concealed during pre‐study briefing using a process that calibrates the participant's expectations of sensations from study interventions. Participants can be briefed that some types of non‐invasive electrical stimulation techniques do not produce sensations during stimulation (i.e. microcurrent therapy) and that they may or may not experience sensations from the TENS device (<a href="./references#CD012172-bbs2-0021" title="BennettMI , HughesN , JohnsonMI . Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: low fidelity may explain negative findings. Pain2011;156(2):1226‐32. ">Bennett 2011</a>). The sham (no current) device can look and behave similarly to the intervention device (e.g. identical appearance of the device, flashing lights, and functioning display panel) and participants can be instructed to use the device at a predetermined setting on the display. Blinding can be monitored by asking participants whether they believed that "...the device was functioning properly?" (<a href="./references#CD012172-bbs2-0040" title="DeyoR , WalshN , SchoenfeldL , RamamurthyS . Can trials of physical treatments be blinded? The example of transcutaneous electrical nerve stimulation for chronic pain. American Journal of Physical Medicine and Rehabilitation1990;69(1):6‐10. ">Deyo 1990</a>). <a href="./references#CD012172-bbs2-0021" title="BennettMI , HughesN , JohnsonMI . Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: low fidelity may explain negative findings. Pain2011;156(2):1226‐32. ">Bennett 2011</a> also examined aspects of fidelity that may contribute to underestimation of the effects of TENS and found that the adequacy of the TENS intervention (i.e. the appropriateness of the TENS technique) was the main area of concern. Other factors contributing to underestimation of the effects of TENS were: a lack of instruction on how best to administer TENS especially when self‐administering TENS; assessment of adherence; inadequate reporting of the TENS regimen during use; and failure to standardise or report concurrent analgesia and to assess comparability between groups. We intended to undertake a subgroup analysis of TENS administered as a sole treatment versus TENS administered in combination with other treatments if sufficient data were available. </p> </section> </section> <section id="CD012172-sec-0028"> <h3 class="title" id="CD012172-sec-0028">Why it is important to do this review</h3> <p>TENS is used extensively to manage painful conditions because it has few contraindications or reported adverse effects and has no potential for overdose (<a href="./references#CD012172-bbs2-0062" title="JohnsonMI . Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014. ">Johnson 2014</a>). One Cochrane Review by <a href="./references#CD012172-bbs2-0063" title="JohnsonMI , PaleyCA , HoweTA , SlukaKA . Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD006142.pub3] ">Johnson 2015a</a> concluded that there was tentative evidence that TENS reduces pain intensity when administered as a stand‐alone treatment for acute pain in adults and a non‐Cochrane meta‐analysis found superiority of TENS over placebo for reducing postoperative analgesic consumption (<a href="./references#CD012172-bbs2-0024" title="BjordalJM , JohnsonMI , LjunggreenAE . Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta‐analysis with assessment of optimal treatment parameters for postoperative pain. European Journal of Pain2003;7:181‐8. ">Bjordal 2003</a>). Another Cochrane Review found only limited evidence of effect for labour pain (<a href="./references#CD012172-bbs2-0041" title="DowswellT , BedwellC , LavenderT , NeilsonJP . Transcutaneous electrical nerve stimulation for pain relief in labour. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD007214.pub2] ">Dowswell 2009</a>). In 2008, one Cochrane Review on TENS for chronic pain was inconclusive (<a href="./references#CD012172-bbs2-0128" title="NnoahamKE , KumbangJ . Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD003222.pub3] ">Nnoaham 2008</a>); although the 2008 review has now been withdrawn, our new review will partly serve to update it, focusing on fibromyalgia alone. Most Cochrane Reviews on specific chronic pain conditions have found the evidence to be inconclusive (e.g. osteoarthritis of the knee (<a href="./references#CD012172-bbs2-0106" title="RutjesAW , NueschE , SterchiR , KalichmanL , HendriksE , OsiriM , et al. Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002823.pub2] ">Rutjes 2009</a>)) or insufficient to make a judgement (e.g. chronic low back pain (<a href="./references#CD012172-bbs2-0066" title="KhadilkarA , MilneS , BrosseauL , RobinsonV , SaginurM , SheaB . Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low‐back pain. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD003008.pub3] ">Khadilkar 2008</a>), cancer pain (<a href="./references#CD012172-bbs2-0056" title="HurlowA , BennettMI , RobbKA , JohnsonMI , SimpsonKH , OxberrySG . Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD006276.pub3] ">Hurlow 2012</a>), and phantom pain and stump pain (<a href="./references#CD012172-bbs2-0064" title="JohnsonMI , MulveyMR , BagnallAM . Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults. Cochrane Database of Systematic Reviews2015, Issue 8. [DOI: 10.1002/14651858.CD007264.pub3] ">Johnson 2015b</a>)). Non‐Cochrane meta‐analyses have found superiority of TENS over placebo for chronic musculoskeletal pain (<a href="./references#CD012172-bbs2-0059" title="JohnsonM , MartinsonM . Efficacy of electrical nerve stimulation for chronic musculoskeletal pain: a meta‐analysis of randomized controlled trials. Pain2007;130(1‐2):157‐65. ">Johnson 2007</a>), and osteoarthritis of the knee (<a href="./references#CD012172-bbs2-0025" title="BjordalJM , JohnsonMI , Lopes‐MartinsRA , BogenB , ChowR , LjunggrenAE . Short term efficacy of physical interventions in osteoarthritis knee pain: a systematic review and meta‐analysis of randomised placebo‐controlled trials. BMC Musculoskeletal Disorders2007;22(8):8‐51. ">Bjordal 2007</a>). Often systematic reviews and meta‐analyses are hindered by methodological weaknesses including suboptimal TENS interventions and inadequate study sample sizes (<a href="./references#CD012172-bbs2-0021" title="BennettMI , HughesN , JohnsonMI . Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: low fidelity may explain negative findings. Pain2011;156(2):1226‐32. ">Bennett 2011</a>: <a href="./references#CD012172-bbs2-0060" title="JohnsonMI , WalshDM . Pain: continued uncertainty of TENS effectiveness for pain relief. Nature Reviews Rheumatology2010;6(6):314‐6. ">Johnson 2010</a>; <a href="./references#CD012172-bbs2-0112" title="SlukaKA , BjordalJM , MarchandS , RakelBA . What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Physical Therapy2013;93(10):1397‐402. ">Sluka 2013</a>). One overview of Cochrane Reviews of TENS for chronic pain is in development (<a href="./references#CD012172-bbs2-0029" title="CatleyMJ , GibsonW , WandBM , MeadsC , O'ConnellNE . Transcutaneous Electrical Nerve Stimulation (TENS) for chronic pain ‐ an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011890] ">Catley 2015</a>), and a new review on TENS for neuropathic pain in adults, which was developed from <a href="./references#CD012172-bbs2-0036" title="ClaydonLS , ChestertonLS , JohnsonMI , HerbisonGP , BennettMI . Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD008756.pub2] ">Claydon 2010</a>, has been published (<a href="./references#CD012172-bbs2-0046" title="GibsonW , WandBM , O'ConnellNE . Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database of Systematic Reviews2017, Issue 9. [DOI: 10.1002/14651858.CD011976] ">Gibson 2017</a>). </p> <p>There is evidence that electrode placement site, frequency, and intensity of stimulation influence TENS outcome although the precise nature of the interaction is unknown (<a href="./references#CD012172-bbs2-0033" title="ChestertonLS , FosterNE , WrightCC , BaxterGD , BarlasP . Effects of TENS frequency, intensity and stimulation site manipulation on pressure pain thresholds in healthy human subjects. Pain2003;106(1‐2):73‐80. ">Chesterton 2003</a>; <a href="./references#CD012172-bbs2-0035" title="ClaydonLS , ChestertonLS , BarlasP , SimJ . Effects of simultaneous dual‐site TENS stimulation on experimental pain. European Journal of Pain2008;12(6):696‐704. ">Claydon 2008b</a>; <a href="./references#CD012172-bbs2-0037" title="ClaydonLS , ChesteronLS , BarlasP , SimJ . Effects of alternating frequency TENS on experimental pain in healthy human participants: a randomised controlled trial. Clinical Journal of Pain2013;29(6):533‐9. ">Claydon 2013</a>). Studies on healthy people exposed to experimental pain and systematic reviews with meta‐analyses of people with painful conditions have found that a strong, non‐painful TENS sensation, at or close to the site of pain, produces optimal analgesic efficacy (<a href="./references#CD012172-bbs2-0016" title="AarskogR , JohnsonMI , DemminkJH , LofthusA , IversenV , Lopes‐MartinsR , et al. Is mechanical pain threshold after transcutaneous electrical nerve stimulation (TENS) increased locally and unilaterally? A randomized placebo controlled trial in healthy subjects. Physiotherapy Research International2007;12(4):251‐63. ">Aarskog 2007</a>; <a href="./references#CD012172-bbs2-0025" title="BjordalJM , JohnsonMI , Lopes‐MartinsRA , BogenB , ChowR , LjunggrenAE . Short term efficacy of physical interventions in osteoarthritis knee pain: a systematic review and meta‐analysis of randomised placebo‐controlled trials. BMC Musculoskeletal Disorders2007;22(8):8‐51. ">Bjordal 2007</a>; <a href="./references#CD012172-bbs2-0032" title="ChenCC , JohnsonMI . Differential frequency effects of strong non‐painful transcutaneous electrical nerve stimulation (TENS) on experimentally‐induced ischaemic pain in healthy human participants. Clinical Journal of Pain2011;27(5):434‐41. ">Chen 2011</a>; <a href="./references#CD012172-bbs2-0034" title="ClaydonLS , ChestertonLS . Does transcutaneous electrical nerve stimulation (TENS) produce 'dose' responses? A review of systematic reviews on chronic pain. Physical Therapy Reviews2008;13(6):450‐63. ">Claydon 2008a</a>; <a href="./references#CD012172-bbs2-0096" title="MoranF , LeonardT , HawthorneS , HughesCM , McCrum‐GardnerE , JohnsonMI , et al. Hypoalgesia in response to transcutaneous electrical nerve stimulation (TENS) depends on stimulation intensity. Journal of Pain2011;12(8):929‐35. ">Moran 2011</a>). Central sensitisation contributes to pain associated with fibromyalgia and therefore TENS may be beneficial because it has been shown to reduce this (<a href="./references#CD012172-bbs2-0074" title="MaYT , SlukaKA . Reduction in inflammation‐induced sensitization of dorsal horn neurons by transcutaneous electrical nerve stimulation in anesthetized rats. Experimental Brain Research2001;137(1):94‐102. ">Ma 2001</a>). </p> <p>Exercise is recommended as a treatment for fibromyalgia (<a href="./references#CD012172-bbs2-0075" title="MacfarlaneGJ , KronischC , DeanLE , AtzeniF , HäuserW , FlußE , et al. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases2017;76:318‐28. ">Macfarlane 2017</a>) and evidence suggests that aerobic exercise may slightly decrease pain intensity (<a href="./references#CD012172-bbs2-0023" title="BidondeJ , BuschAJ , SchachterCL , OverendTJ , KimSY , GóesSM , et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database of Systematic Reviews2017, Issue 6. [DOI: 10.1002/14651858.CD012700] ">Bidonde 2017</a>), although adherence to exercise programmes may be poor due to pain and fatigue (<a href="./references#CD012172-bbs2-0022" title="BidondeJ , BuschAJ , WebberSC , SchachterCL , DanyliwA , OverendTJ , et al. Aquatic exercise training for fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD011336] ">Bidonde 2014</a>; <a href="./references#CD012172-bbs2-0027" title="BuschAJ , SchachterCL , OverendTJ , PelosoPM , BarberKA . Exercise for fibromyalgia: a systematic review. Journal of Rheumatology2008;35(6):1130‐44. ">Busch 2008</a>). As TENS reduces pain during movement, it may be useful as an adjunct to assist with participation in exercise and activities of daily living. Some clinical studies have been published on TENS for managing symptoms associated with fibromyalgia (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>), and there is a published protocol for a double‐blind randomised clinical study that has yet to be completed (<a href="./references#CD012172-bbs2-0015" title="NoehrenB , DaileyDL , RakelBA , VanceCG , ZimmermanMB , CroffordLJ , et al. Effect of transcutaneous electrical nerve stimulation on pain, function, and quality of life in fibromyalgia: a double‐blind randomized clinical trial. Physical Therapy2015;95(1):129‐40. ">Noehren 2015</a>). Two large questionnaire surveys on people with fibromyalgia revealed that 21% of people in the US (<a href="./references#CD012172-bbs2-0020" title="BennettRM , JonesJ , TurkDC , RussellIJ , MatallanaL . An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders2007;8(1):27. ">Bennett 2007</a>) and 17% of Germans with fibromyalgia (<a href="./references#CD012172-bbs2-0057" title="HäuserW , JungE , Erbslöh‐MöllerB , GesmannM , Kühn‐BeckerH , PetermannF , et al. The German fibromyalgia consumer reports ‐ a cross‐sectional survey. BMC Musculoskeletal Disorders2012;13(1):74. ">Häuser 2012</a>) reported use of TENS for symptom control. To date, only one systematic review exists which looks at physiotherapy and physical agents used for fibromyalgia, of which TENS is included (<a href="./references#CD012172-bbs2-0121" title="WinkelmannA , HäuserW , FriedelE , Moog‐EganM , SeegerD , SettanM , et al. Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta‐analysis and guideline [Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften]. Schmerz (Berlin, Germany)2012;26(3):276‐86. ">Winkelmann 2012</a>). Three randomised controlled trials (RCTs) with 82 participants and mean study duration of five (range three to five) weeks were analysed but studies were found to be of low methodological quality and incompletely reported. The authors concluded that TENS was not an effective treatment option for fibromyalgia. An updated systematic review of the current evidence of the effects of TENS for fibromyalgia is needed so that health professionals, researchers, and people with fibromyalgia can make informed decisions about its use. </p> <p>The standards used to assess evidence in chronic pain studies have changed substantially, with particular attention being paid to study duration, withdrawals, and statistical imputation following withdrawal, all of which can substantially alter estimates of efficacy. The most important change is the move from using mean pain scores, or mean change in pain scores, to the number of people who have a large decrease in pain (by at least 50%) and who continue in treatment, ideally in studies of eight to 12 weeks or longer. Pain intensity reduction of 50% or more has been shown to correlate with improvements in comorbid symptoms, function, and quality of life. These standards are set out in the reference guide for pain studies (<a href="./references#CD012172-bbs2-0101" title="PaPaS author and referee guidance. papas.cochrane.org/papas‐documents (accessed 22 January 2013). ">PaPaS 2012</a>). This Cochrane Review assessed evidence using methods that make both statistical and clinical sense, and will use developing criteria for what constitutes reliable evidence in chronic pain (<a href="./references#CD012172-bbs2-0082" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>). The studies included and analysed needed to meet a minimum of reporting quality (blinding, randomisation), validity (duration, dose and timing, diagnosis, outcomes, etc.), and size (ideally at least 500 participants in a comparison in which the NNTB is four or above; <a href="./references#CD012172-bbs2-0079" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. ">Moore 1998</a>). This approach sets high standards and marks a departure from how reviews were conducted previously. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012172-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012172-sec-0029"></div> <p>To assess the analgesic efficacy and adverse events of TENS alone or added to usual care (including exercise) compared with placebo (sham) TENS; no treatment; exercise alone; or other treatment including medication, electroacupuncture, warmth therapy, or hydrotherapy for fibromyalgia in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012172-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012172-sec-0030"></div> <section id="CD012172-sec-0031"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012172-sec-0032"> <h4 class="title">Types of studies</h4> <p>We included RCTs or quasi‐randomised trials of TENS treatment. We included single treatment interventions without follow‐up and gave credence to studies that delivered at least two weeks of treatment and had a study duration of at least eight weeks. We included cross‐over and parallel‐group study designs. We required full journal publication, with the exception of online clinical study results summaries of otherwise unpublished clinical studies, and abstracts with sufficient data for analysis. We did not include short abstracts (usually meeting reports). We excluded studies that were non‐randomised, studies of experimental pain, case reports, and clinical observations. </p> </section> <section id="CD012172-sec-0033"> <h4 class="title">Types of participants</h4> <p>We included studies of adults aged 18 years or above with pain due to fibromyalgia diagnosed using either the Wolfe (<a href="./references#CD012172-bbs2-0124" title="WolfeF , SymtheHA , YunusMB , BennettRM , BombardierC , GoldenbergDL , et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism1990;33:160‐72. ">Wolfe 1990</a>; <a href="./references#CD012172-bbs2-0125" title="WolfeF , ClauwDJ , FitzcharlesMA , ColdenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research2010;62:600‐10. ">Wolfe 2010</a>) or earlier criteria in the case of older studies (e.g. <a href="./references#CD012172-bbs2-0049" title="GoldenbergDL . Fibromyalgia syndrome: an emerging but controversial condition. JAMA1987;257:2782‐7. ">Goldenberg 1987</a>). </p> </section> <section id="CD012172-sec-0034"> <h4 class="title">Types of interventions</h4> <p>We included studies that evaluated TENS administered using non‐invasive techniques for pain relief. We excluded invasive techniques such as percutaneous electrical nerve stimulation. We included TENS administered using a standard TENS device (<a href="./references#CD012172-bbs2-0062" title="JohnsonMI . Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014. ">Johnson 2014</a>), regardless of the device manufacturer, which delivered biphasic or monophasic pulsed electrical currents that were greater than 1 mA using at least two surface electrodes. We excluded TENS delivered using single probe electrodes (i.e. TENS pens) and studies investigating 'TENS‐like' devices such as neuromuscular electrical stimulation (NMES) devices and interferential current devices. We included studies that administered TENS at intensities that produced perceptible TENS sensations during stimulation. To explore suboptimal stimulation, we conducted a subgroup analysis to compare TENS at intensities described as 'strong' (optimal) versus those described as 'barely perceptible,' 'faint,' or 'mild' (suboptimal). We included TENS administered on an area of the body that was sensate at either the site of pain or over nerve bundles proximal (or near) to the site of pain. We included AL‐TENS delivered at strong intensities to generate muscle twitches. We only included TENS delivered at acupuncture points if the point was lying over nerve bundles proximal (or near) to the site of pain. We included any TENS parameters meeting these criteria; any duration or regularity of TENS treatment; and either self‐applied or therapist‐applied TENS treatment. We included TENS administered as a sole treatment or in combination with usual care. We included studies that evaluated TENS versus: </p> <p> <ul id="CD012172-list-0001"> <li> <p>placebo TENS (e.g. sham (no current) TENS device);</p> </li> <li> <p>no treatment or waiting list control;</p> </li> <li> <p>usual care (including exercise);</p> </li> <li> <p>other treatment.</p> </li> </ul> </p> <p>Sham credibility is an issue in TENS studies (<a href="./references#CD012172-bbs2-0040" title="DeyoR , WalshN , SchoenfeldL , RamamurthyS . Can trials of physical treatments be blinded? The example of transcutaneous electrical nerve stimulation for chronic pain. American Journal of Physical Medicine and Rehabilitation1990;69(1):6‐10. ">Deyo 1990</a>). We defined a sham TENS device as a device similar to the one used in the active group but where the current output was modified so that there was: no electrical current, a barely perceptible electrical current, or electrical current that ceased within one minute (<a href="./references#CD012172-bbs2-0104" title="RakelB , CooperN , AdamsHJ , MesserBR , Frey LawLA , DannenDR , et al. A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment. Journal of Pain2010;11(3):230‐8. ">Rakel 2010</a>; <a href="./references#CD012172-bbs2-0112" title="SlukaKA , BjordalJM , MarchandS , RakelBA . What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Physical Therapy2013;93(10):1397‐402. ">Sluka 2013</a>). We excluded studies where it was not possible to isolate the effects of TENS from other treatments. </p> </section> <section id="CD012172-sec-0035"> <h4 class="title">Types of outcome measures</h4> <p>We anticipated that studies would use a variety of outcome measures, with the majority of studies using standard subjective scales (numerical rating scale (NRS) or visual analogue scale (VAS)) for pain intensity or pain relief, or both. We included measures of pain at rest and pain on movement. We were particularly interested in Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) definitions for moderate and substantial benefit in chronic pain studies (<a href="./references#CD012172-bbs2-0042" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105‐21. ">Dworkin 2008</a>). These were defined as: </p> <p> <ul id="CD012172-list-0002"> <li> <p>at least 30% pain relief over baseline (moderate);</p> </li> <li> <p>at least 50% pain relief over baseline (substantial);</p> </li> <li> <p>much or very much improved on Patient Global Impression of Change scale (PGIC; moderate);</p> </li> <li> <p>very much improved on PGIC (substantial).</p> </li> </ul> </p> <p>These outcomes concentrate on dichotomous outcomes where pain responses do not follow a normal (Gaussian) distribution. People with chronic pain desire high levels of pain relief, ideally more than 50%, and ideally with no worse than mild pain (<a href="./references#CD012172-bbs2-0092" title="MooreRA , StraubeS , AldingtonD . Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple universal outcome. Anaesthesia2013;68(4):400‐12. ">Moore 2013b</a>; <a href="./references#CD012172-bbs2-0099" title="O'BrienEM , StaudRM , HassingerAD , McCullochRC , CraggsJG , AtchisonJW , et al. Patient‐centered perspective on treatment outcomes in chronic pain. Pain Medicine2010;11(1):6‐15. [DOI: 10.1111/j.1526‐4637.2009.00685.x] ">O'Brien 2010</a>). We included 'Summary of findings' tables as set out in the author guide (<a href="./references#CD012172-bbs2-0101" title="PaPaS author and referee guidance. papas.cochrane.org/papas‐documents (accessed 22 January 2013). ">PaPaS 2012</a>) where sufficient data were available. The 'Summary of findings' table included outcomes of at least 30% and at least 50% pain intensity reduction, PGIC, withdrawals due to adverse events, serious adverse events, and death. We used the GRADE approach to assess the quality of evidence related to each of the key outcomes listed in <a href="#CD012172-sec-0035">Types of outcome measures</a> (Chapter 12, <a href="./references#CD012172-bbs2-0054" title="HigginsJPT , GreenSE , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), as appropriate. We planned to extract outcome measurement data before, during, and after the intervention, where data were available. </p> <section id="CD012172-sec-0036"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012172-list-0003"> <li> <p>Participant‐reported pain relief of 30% or greater, compared with baseline.</p> </li> <li> <p>Participant‐reported pain relief of 50% or greater, compared with baseline.</p> </li> <li> <p>PGIC much or very much improved.</p> </li> <li> <p>PGIC very much improved.</p> </li> </ul> </p> </section> <section id="CD012172-sec-0037"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012172-list-0004"> <li> <p>Any pain‐related outcome indicating some improvement (e.g. outcomes from continuous data such as participant‐reported change in pain intensity reported as mean data. We intended to make generalised statements if baseline status was heterogeneous, and large effects in some participants were masked by small effects in others). </p> </li> <li> <p>Any participant‐reported change in health‐related quality of life, including activities of daily living and fatigue, using any validated tool (e.g. 36‐item Short Form (SF‐36), 6‐item Short Form (SF‐6), Euroqol). </p> </li> <li> <p>Withdrawals due to lack of efficacy, adverse events, and for any cause.</p> </li> <li> <p>Participants who experienced any adverse event.</p> </li> <li> <p>Participants who experienced any serious adverse event. Serious adverse events typically included any untoward medical occurrence or effect that at any dose resulted in death, was life‐threatening, required hospitalisation or prolongation of existing hospitalisation, resulted in persistent or significant disability or incapacity, was a congenital anomaly or birth defect, was an 'important medical event' that may have jeopardised the person, or may have required an intervention to prevent one of the above characteristics or consequences. </p> </li> <li> <p>Specific adverse events, particularly skin reactions, somnolence, and dizziness.</p> </li> <li> <p>Any disability‐related or mental health‐related outcome.</p> </li> </ul> </p> </section> </section> </section> <section id="CD012172-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012172-sec-0039"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases using a combination of controlled vocabulary (i.e. MeSH and free‐text terms) to identify published articles: </p> <p> <ul id="CD012172-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2016 Issue 12) via CRSO searched on 18 January 2017; </p> </li> <li> <p>MEDLINE (via Ovid) from 1950 to 18 January 2017;</p> </li> <li> <p>Embase (via Ovid) from 1980 to 18 January 2017;</p> </li> <li> <p>CINAHL (via EBSCO) from 1982 to 18 January 2017;</p> </li> <li> <p>PsycINFO (via Ovid) from 1806 to 18 January 2017;</p> </li> <li> <p>LILACS (via Birme) from 1982 to 18 January 2017;</p> </li> <li> <p>PEDRO from 1929 to 18 January 2017;</p> </li> <li> <p>Web of Science (SCI, SSCI, CPCI, SCPCI‐SSH) to 18 January 2017;</p> </li> <li> <p>AMED (via Ovid) from 1985 to 18 January 2017;</p> </li> <li> <p>SPORTDiscus (via EBSCO) from 1975 to 18 January 2017.</p> </li> </ul> </p> <p>There were no language restrictions. We tailored the searches to the individual databases. We adapted the MEDLINE search strategy for the other databases listed. The search strategy combined the subject‐specific search with phase one and two of the Cochrane Sensitive Search Strategy for RCTs (as published in Sections 6.3.2.1, 6.3.3.2, and 6.4.11.1 in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012172-bbs2-0054" title="HigginsJPT , GreenSE , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>)). The search strategies can be found in <a href="./appendices#CD012172-sec-0138">Appendix 2</a>. We identified all relevant studies irrespective of language and translated articles when possible. </p> </section> <section id="CD012172-sec-0040"> <h4 class="title">Searching other resources</h4> <p>We reviewed the bibliographies of RCTs and review articles, and searched clinical trial databases (e.g. ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>), World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP, <a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>), and <i>meta</i> Register of Controlled Trials (<i>m</i>RCT, <a href="http://www.isrctn.com/page/mrct" target="_blank">www.isrctn.com/page/mrct</a>) to identify additional published or unpublished data. We did not contact investigators or study sponsors. </p> </section> </section> <section id="CD012172-sec-0041"> <h3 class="title" id="CD012172-sec-0041">Data collection and analysis</h3> <section id="CD012172-sec-0042"> <h4 class="title">Selection of studies</h4> <p>We determined eligibility of studies for inclusion first by title, then by reading the abstract of each record identified by the search. We eliminated records where it was clear from the abstract that they did not satisfy the inclusion criteria, then obtained full copies of the remaining records. Two review authors (MIJ, CAP) made the decisions by reading these records independently and reached agreement by discussion. Disagreements at any stage of the process were/would have been resolved by consensus using a third review author as arbiter (GJ). We did not anonymise the records of studies in any way before assessment. We created a PRISMA flow chart (<a href="./references#CD012172-bbs2-0054" title="HigginsJPT , GreenSE , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>; <a href="./references#CD012172-bbs2-0072" title="LiberatiA , AltmanDG , TezlaffJ , MulrowC , GotzschePC , IoannidisJP , et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate healthcare interventions: explanations and elaboration. BMJ2009;339:b2700. ">Liberati 2009</a>). </p> </section> <section id="CD012172-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LSC, CAP) extracted data of included studies independently using a standard form and checked for agreement before entry into Review Manager 5 (<a href="./references#CD012172-bbs2-0105" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Disagreements were resolved by consensus using the arbiter (MIJ). We included information about: </p> <p> <ul id="CD012172-list-0006"> <li> <p>country of origin;</p> </li> <li> <p>study design: cross‐over, parallel‐group;</p> </li> <li> <p>study duration;</p> </li> <li> <p>study participants: age, gender, fibromyalgia diagnostic criteria used, duration of pain and symptoms; </p> </li> <li> <p>sample size: active and comparator groups;</p> </li> <li> <p>concomitant treatments: pharmacological and non‐pharmacological;</p> </li> <li> <p>TENS intervention(s) used: type, electrical parameters, electrode location, perceptual experience during intervention including intensity of stimulation, dosing regimen; </p> </li> <li> <p>comparison group(s) used: placebo, no treatment, usual treatment, other treatment, dosing regimen; </p> </li> <li> <p>outcomes: time points used including follow‐up, withdrawals;</p> </li> <li> <p>adverse and serious adverse effects;</p> </li> <li> <p>other: sponsorship, country of origin, conflict of interest statements.</p> </li> </ul> </p> <p>We used these data to populate the <a href="./references#CD012172-sec-0145" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD012172-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LSC, CAP) independently assessed risk of bias for each trial, using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012172-bbs2-0054" title="HigginsJPT , GreenSE , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), with disagreements resolved by consensus with a third review author (MIJ) acing as arbiter. We assessed the following for each trial. </p> <p> <ul id="CD012172-list-0007"> <li> <p><b>Random sequence generation (selection bias)</b>. We assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, e.g. random number table; computer random number generator); unclear risk of bias (method used to generate sequence not clearly stated). We excluded studies using a non‐random process (e.g. odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p><b>Allocation concealment (selection bias)</b>. The method used to conceal allocation to interventions prior to assignment determines whether the intervention allocation could have been foreseen in advance of, or during, recruitment or changed after assignment. We assessed the methods as: low risk of bias (e.g. telephone or central randomisation; consecutively numbered, sealed, opaque envelopes); unclear risk of bias (method not clearly stated); high risk of bias (studies that did not conceal allocation (e.g. open list). </p> </li> <li> <p><b>Blinding of participants and personnel (performance bias): participants, and care providers administering TENS</b>. </p> </li> </ul> <ul class="plain" id="CD012172-list-0008"> <li> <ul id="CD012172-list-0009"> <li> <p><i>Blinding of participants:</i> low risk of bias (participants blinded to allocated intervention and unlikely that blinding broken); unclear risk of bias (insufficient information to permit judgement of low/high risk of bias); high risk of bias (participants not blinded to allocated intervention OR participants blinded to allocated intervention but it was likely that blinding may have been broken). </p> </li> <li> <p><i>Blinding of personnel (care provider(s) administering TENS)</i>: low risk of bias (care provider blinded to allocated intervention and unlikely that blinding broken); unclear risk of bias (insufficient information to permit judgement of low/high risk of bias); high risk of bias (care provider not blinded to allocated intervention and the two interventions clearly identifiable to the care provider as experimental and control OR care provider blinded to allocated intervention but likely that blinding was broken). </p> </li> </ul> </li> </ul> <ul id="CD012172-list-0010"> <li> <p><b>Blinding of outcome assessment (detection bias): outcome assessors</b>. </p> <ul id="CD012172-list-0011"> <li> <p><i>Blinding of assessor</i>: low risk of bias (outcome assessor (including 'participants' with respect to self‐report outcomes) blinded to participants' allocated intervention and unlikely that blinding broken); unclear risk of bias (insufficient information to permit judgement of low/high risk of bias); high risk of bias (outcome assessor (including 'participants' with respect to self‐report outcomes) unblinded to participants' allocated intervention OR outcome assessor blinded to allocated intervention but likely that blinding was broken)). </p> </li> </ul> </li> <li> <p><b>Incomplete outcome data (dropouts)</b>. We checked for possible attrition bias by considering if participant dropout was acceptable and described: low risk of bias (less than 20% dropout and appeared to be random with numbers per group provided along with reasons for dropout); unclear risk of bias (less than 20% and unclear if random with numbers per group and reasons for dropout not described); high risk of bias (greater than 20% dropout). </p> </li> <li> <p><b>Incomplete outcome data (protocol violations)</b>. We considered if participants were analysed as per original group allocation: low risk of bias (if participants were analysed in the group to which they were originally assigned); unclear risk of bias (where insufficient information was provided to determine if analysis was per protocol or intention‐to‐treat (ITT)); high risk of bias (where per protocol analysis was used, where available data were not analysed or participants' data were included in the group to which they were not originally assigned). </p> </li> <li> <p><b>Selective reporting</b>. We assessed whether studies selectively reported outcomes. We assessed the methods as: low risk of bias (study protocol was available and all prespecified outcomes were reported or study protocol was not available but all expected outcomes were reported); unclear risk of bias (inadequate information to allow judgement of a study to be classified as 'low risk' or 'high risk'); high risk of bias (incomplete reporting of specified outcomes. One or more primary outcomes were reported using measurements or analysis that were not prespecified. One or more of the primary outcomes was not prespecified. One or more outcomes of interest were reported incompletely and could not be entered into a meta‐analysis. Results for a key outcome expected to be reported were excluded). </p> </li> <li> <p><b>Size of study (checking for biases confounded by small size)</b>. We assessed this as: low risk of bias (200 participants or more per treatment arm); unclear risk of bias (50 to 199 participants per treatment arm); high risk of bias (fewer than 50 participants per treatment arm). </p> </li> <li> <p><b>Other sources of bias</b>. We considered other factors such as whether studies were stopped early, there were differences between groups at baseline, the timing of outcome measurement, cointervention comparability, and funding declarations. </p> </li> </ul> </p> </section> <section id="CD012172-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>Where available and appropriate we presented quantitative and ITT data. For dichotomous data (responder analyses), we used the Initiative on Methods, Measurement and Pain Assessment in Clinical Trials (IMMPACT) definitions for interpreting the clinical importance in change in outcome measures compared with baseline (<a href="./references#CD012172-bbs2-0042" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105‐21. ">Dworkin 2008</a>). We intended to calculate risk ratio (RR) and risk difference (RD) with 95% confidence intervals (CI) for dichotomised outcome measures. We intended to calculate the NNTB as an absolute measure of treatment effect where possible. We intended to present pain outcomes collected as continuous data on identical scales as mean difference (MD) with 95% CI. We intended to present pain outcomes collected as continuous data using different scales as standardised mean difference (SMD) with 95% CI. We intended to interpret reductions in pain over baseline as follows: </p> <p> <ul id="CD012172-list-0012"> <li> <p>less than 15%: no important change;</p> </li> <li> <p>15% or greater: minimally important change;</p> </li> <li> <p>30% or greater: moderately important change;</p> </li> <li> <p>50% or greater: substantially important change.</p> </li> </ul> </p> <p>For health‐related quality of life data, we intended to consider a clinical difference greater than 10% of the scale employed to be minimally important (<a href="./references#CD012172-bbs2-0044" title="FurlanAD , PennickV , BombardierC , vanTulderM . Updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine2009;34:1929‐41. ">Furlan 2009</a>). </p> <p>The IMMPACT thresholds are based on estimates of the degree of within‐person change from baseline that participants might consider to be clinically important. We expected that the studies in this review would most likely present effect sizes as the mean between‐group change between intervention groups. There is little consensus or evidence regarding what the threshold should be for a clinically important difference in pain intensity based on the between‐group difference during or after the intervention. It has been found that in pharmacological studies, pain outcomes for acute pain (<a href="./references#CD012172-bbs2-0087" title="MooreRA , StraubeS , PaineJ , DerryS , McQuayHJ . Minimum efficacy criteria for comparisons between treatments using individual patient meta‐analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain2011;152(5):982‐9. [DOI: 10.1016/j.pain.2010.11.030] ">Moore 2011b</a>; <a href="./references#CD012172-bbs2-0088" title="MooreRA , MhuircheartaighRJ , DerryS , McQuayHJ . Mean analgesic consumption is inappropriate for testing analgesic efficacy in post‐operative pain: analysis and alternative suggestion. European Journal of Anaesthesiology2011;28(6):427‐32. [DOI: 10.1097/EJA.0b013e328343c569] ">Moore 2011c</a>), back pain (<a href="./references#CD012172-bbs2-0085" title="MooreRA , SmugarSS , WangH , PelosoPM , GammaitoniA . Numbers‐needed‐to‐treat analyses ‐ do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo‐controlled chronic low back pain trials. Pain2010;151(3):592‐7. [DOI: 10.1016/j.pain.2010.07.013] ">Moore 2010d</a>), arthritis (<a href="./references#CD012172-bbs2-0084" title="MooreRA , MooreOA , DerryS , PelosoPM , GammaitoniAR , WangH . Responder analysis for pain relief and numbers needed to treat in a meta‐analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases2010;69(2):374‐9. [DOI: 10.1136/ard.2009.107805] ">Moore 2010c</a>), and fibromyalgia (<a href="./references#CD012172-bbs2-0115" title="StraubeS , DerryS , MooreRA , PaineJ , McQuayHJ . Pregabalin in fibromyalgia ‐ responder analysis from individual patient data. BMC Musculoskeletal Disorders2010;11:150. [DOI: 10.1186/1471‐2474‐11‐150] ">Straube 2010</a>), tend to have a U‐shaped rather than a bell‐shaped distribution, with some people experiencing a substantial reduction in symptoms, some minimal to no improvement, and few experiencing mean (moderate) improvement. Thus, data expressed as means may be misleading as a small mean between‐group effect size may represent a proportion of participants that actually responded very well to the intervention (<a href="./references#CD012172-bbs2-0093" title="MooreRA , DerryS , WiffenPJ . Challenges in design and interpretation of chronic pain trials. British Journal of Anaesthesia2013;111(1):38‐45. ">Moore 2013c</a>; <a href="./references#CD012172-bbs2-0094" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2014;14(1):79‐94. ">Moore 2014a</a>). It is unknown whether outcomes are commonly bimodally distributed in studies of TENS. The advantage of focusing on the between‐group difference is that it is the only direct estimate of the mean specific effect of the intervention and a small mean between‐group effect might accurately represent very small effects of the intervention for most or all people. We intended to use a threshold of 10 mm on a 0‐ to 100‐mm VAS for minimally important outcome for pain when analysing mean between‐group change, in line with the OMERACT 12 group, which states that the proportion of people achieving one or more thresholds of improvement from baseline pain (e.g. greater than 10%, 20% or greater, 30% or greater, 50% or greater) should be reported in addition to mean change (<a href="./references#CD012172-bbs2-0028" title="BusseJW , BartlettSJ , DougadosM , JohnstonBC , GuyattGH , KirwanJR , et al. Optimal strategies for reporting pain in clinical trials and systematic reviews: recommendations from an OMERACT 12 workshop. Journal of Rheumatology2015; Vol. 42, issue 10:1962‐70. ">Busse 2015</a>). We would interpret these findings with caution as it remains possible that estimates that fall close to this point may reflect a treatment that benefits an appreciable number of people. </p> </section> <section id="CD012172-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <p>We intended to split the control treatment arm between active treatment arms in a single study if the active treatment arms were not combined for analysis. In the unlikely event that the unit of randomisation is not the participant, or where a cross‐over design was used, we intended not to include the data unless a suitable adjustment for the study design had been, or could be, made. We included cross‐over designs but intended only to enter the first period data into the meta‐analysis. If this was not reported, we intended to note this and not include the data. If data were reported appropriately, then we intended to include the data using the generic inverse variance feature. </p> </section> <section id="CD012172-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>We intended to use ITT analysis where the ITT population consisted of participants who were randomised, received at least one dose of the assigned study intervention, and provided at least one post‐baseline assessment. We intended to assign missing participants zero improvement wherever possible. </p> </section> <section id="CD012172-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We intended to deal with clinical heterogeneity by combining studies that examined similar conditions. We performed separate analyses where TENS was compared with different control conditions such as placebo or no treatment control. We intended to examine heterogeneity using visual inspection of forest plots, the I² statistic, and L'Abbé Plots (<a href="./references#CD012172-bbs2-0069" title="L'AbbéKA , DetskyAS , O'RourkeK . Meta‐analysis in clinical research. Annals of Internal Medicine1987;107:224‐33. ">L'Abbé 1987</a>), and the Chi² test, if appropriate. Where significant heterogeneity existed, we intended to explore subgroup analyses. Preplanned comparisons are described in the <a href="#CD012172-sec-0053">Subgroup analysis and investigation of heterogeneity</a> section. </p> </section> <section id="CD012172-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>The aim of this review was to use dichotomous outcomes of known utility and of value to patients (<a href="./references#CD012172-bbs2-0083" title="MooreRA , StraubeS , PaineJ , PhillipsCJ , DerryS , McQuayHJ . Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain2010;149(2):360‐4. [DOI: 10.1016/j.pain.2010.02.039] ">Moore 2010b</a>; <a href="./references#CD012172-bbs2-0084" title="MooreRA , MooreOA , DerryS , PelosoPM , GammaitoniAR , WangH . Responder analysis for pain relief and numbers needed to treat in a meta‐analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases2010;69(2):374‐9. [DOI: 10.1136/ard.2009.107805] ">Moore 2010c</a>; <a href="./references#CD012172-bbs2-0085" title="MooreRA , SmugarSS , WangH , PelosoPM , GammaitoniA . Numbers‐needed‐to‐treat analyses ‐ do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo‐controlled chronic low back pain trials. Pain2010;151(3):592‐7. [DOI: 10.1016/j.pain.2010.07.013] ">Moore 2010d</a>; <a href="./references#CD012172-bbs2-0092" title="MooreRA , StraubeS , AldingtonD . Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple universal outcome. Anaesthesia2013;68(4):400‐12. ">Moore 2013b</a>). It was intended that the review would not depend on what the authors of the original studies chose to report or not, though clearly difficulties would arise in studies failing to report any dichotomous results. We planned to extract and use continuous data, which would probably poorly reflect efficacy and utility and therefore be useful for illustrative purposes only. We intended to assess publication bias using a method designed to detect the amount of unpublished data with a null effect required to make any result clinically irrelevant (usually taken to mean a NNTB of 10 or higher; <a href="./references#CD012172-bbs2-0080" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: McQuayHJ , KalsoE , MooreRA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle (WA): IASP Press, 2008:15‐24. ">Moore 2008</a>). We considered the possible influence of small‐study samples by the risk of bias criterion "study size." If at least 10 studies were included in a meta‐analysis and included studies differed in sample size, we planned to visually inspect funnel plots to explore the likelihood of reporting biases. For studies that used continuous outcomes, we intended to use Egger's test to detect small‐study bias (<a href="./references#CD012172-bbs2-0054" title="HigginsJPT , GreenSE , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We would have interpreted the results of this process cautiously since we were aware that all approaches to the quantification of possible reporting biases have important limitations (<a href="./references#CD012172-bbs2-0080" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: McQuayHJ , KalsoE , MooreRA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle (WA): IASP Press, 2008:15‐24. ">Moore 2008</a>). </p> </section> <section id="CD012172-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We intended to perform pooling of results where adequate data existed using Review Manager 5 (<a href="./references#CD012172-bbs2-0105" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We would have undertaken meta‐analyses of outcome data only from suitably homogeneous studies using a random‐effects model. Where possible, we would have grouped extracted data according to outcome and measurement time points. Time points would have included during stimulation or immediately after stimulation at each treatment session, or both; and post‐intervention follow‐up at less than two weeks' post‐intervention (short‐term), two to seven weeks' post‐intervention (mid‐term), and eight weeks or more post‐intervention (long‐term). </p> <section id="CD012172-sec-0051"> <h5 class="title">Quality of the evidence</h5> <p>For all analyses, we intended to explicitly and clearly present the outcome of the 'Risk of bias' assessments in the reporting. Where inadequate data were found to support statistical pooling, we planned to complete a narrative synthesis. Two review authors (MIJ, CAP) independently rated the quality of the outcomes. We used the GRADE (<a href="./references#CD012172-bbs2-0051" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>) system to rank the quality of the evidence using the GRADEprofiler Guideline Development Tool software (<a href="./references#CD012172-bbs2-0050" title="GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2015. ">GRADEpro GDT 2015</a>), and the guidelines provided in Chapter 12.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012172-bbs2-0054" title="HigginsJPT , GreenSE , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of the body of evidence for each outcome. The GRADE system uses the following criteria for assigning grade of evidence: </p> <p> <ul id="CD012172-list-0013"> <li> <p>high: we are very confident that the true effect lies close to that of the estimate of the effect; </p> </li> <li> <p>moderate: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different; </p> </li> <li> <p>low: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect; </p> </li> <li> <p>very low: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>We decreased the grade rating by one (‐1) or two (‐2) if we identified:</p> <p> <ul id="CD012172-list-0014"> <li> <p>serious (‐1) or very serious (‐2) limitation to study quality;</p> </li> <li> <p>important inconsistency (‐1);</p> </li> <li> <p>some (‐1) or major (‐2) uncertainty about directness;</p> </li> <li> <p>imprecise or sparse data (‐1);</p> </li> <li> <p>high probability of reporting bias (‐1).</p> </li> </ul> </p> <p>We considered single studies to be both inconsistent and imprecise, unless the sample size was greater than 400 participants for continuous data (i.e. more than 200 participants per treatment arm) and greater than 300 events for dichotomous data. We intended to present pooled effects for all primary outcomes and associated GRADE judgements in 'Summary of findings' tables. In certain circumstances, the overall rating for a particular outcome was adjusted as recommended by GRADE guidelines (<a href="./references#CD012172-bbs2-0052" title="GuyattG , OxmanAD , SultanS , BrozekJ , GlasziouP , Alonso‐CoelloP , et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. Journal of Clinical Epidemiology2013;66:151‐7. ">Guyatt 2013a</a>). For example, we considered whether there were so few data that the results were highly susceptible to the random play of chance, or if a study used last observation carried forward (LOCF) imputation in circumstances where there were substantial differences in adverse event withdrawals, one would have no confidence in the result and would need to downgrade the quality of the evidence by three levels to very low quality. Also, in circumstances where no data were reported for an outcome, we reported the level of evidence as very low quality (<a href="./references#CD012172-bbs2-0053" title="GuyattGH , OxmanAD , SantessoN , HelfandM , KunzR , BrozekJ , et al. GRADE guidelines: 12. Preparing summary of findings tables ‐ binary outcomes. Journal of Clinical Epidemiology2013;66:158‐72. ">Guyatt 2013b</a>). In other circumstances, we would not downgrade for imprecision if CIs were wide, if the outcome threshold according to how much harm would be acceptable given a benefit or vice versa. </p> </section> <section id="CD012172-sec-0052"> <h5 class="title">'Summary of findings' tables</h5> <p>We included four 'Summary of findings' tables to present the main findings in a transparent and simple tabular format. In particular, we included key information concerning the quality of evidence, the magnitude of effect of the interventions examined, and the sum of available data on the outcomes participant‐reported pain relief of 30% or greater, participant‐reported pain relief of 50% or greater, PGIC very much improved, PGIC much or very much improved, and withdrawals due to adverse events<i>.</i> </p> </section> </section> <section id="CD012172-sec-0053"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We anticipated too few data for any meaningful subgroup analysis. However, if sufficient data were available, we planned the following analyses: where substantial heterogeneity was found (I² greater than 40%, P &lt; 0.1), we would conduct a subgroup analysis investigating the possible impact of the TENS technique on analgesic efficacy. If appropriate, we would have conducted the following analyses. </p> <p> <ul id="CD012172-list-0015"> <li> <p>Optimal intensity described as 'strong' or greater versus suboptimal intensity described as 'barely perceptible,' 'faint,' or 'mild.' </p> </li> <li> <p>Low‐frequency (10 Hz or less) TENS versus other frequency (e.g. greater than 10 Hz) TENS. </p> </li> <li> <p>Conventional TENS (no visible muscle contraction) versus AL‐TENS (visible phasic muscle contractions). </p> </li> <li> <p>Assessment during TENS versus after TENS.</p> </li> <li> <p>TENS administered as a sole treatment versus TENS administered in combination with other treatments. </p> </li> <li> <p>TENS administered as a single dose versus repetitive dose.</p> </li> <li> <p>Opioid‐treated participants versus opioid‐naïve participants.</p> </li> </ul> </p> </section> <section id="CD012172-sec-0054"> <h4 class="title">Sensitivity analysis</h4> <p>We anticipated too few data for any meaningful sensitivity analysis. However, if sufficient data were available, we planned to analyse the effect of excluding studies with high risk of bias and the effect of using a random‐effects versus a fixed‐effect model. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012172-sec-0055" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012172-sec-0055"></div> <section id="CD012172-sec-0056"> <h3 class="title">Description of studies</h3> <section id="CD012172-sec-0057"> <h4 class="title">Results of the search</h4> <p>Searches identified 245 potentially relevant records. After removal of 61 duplicates, we screened the titles and abstracts of 184 records and obtained and read the full texts of 19 records (<a href="#CD012172-fig-0001">Figure 1</a>). We included eight studies and found four records that were duplicates (<a href="./references#CD012172-sec-0145" title="">Characteristics of included studies</a> table). An abstract by Vance 2015 was categorised as a secondary report of <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> because it presented an analysis of data related to achieving higher‐intensity TENS that was not included in the original study report. We excluded six studies after screening the full text report (<a href="./references#CD012172-sec-0146" title="">Characteristics of excluded studies</a> table). We identified one ongoing study (<a href="./references#CD012172-sec-0147" title="">Characteristics of ongoing studies</a> table). </p> <div class="figure" id="CD012172-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012172-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012172-sec-0058"> <h4 class="title">Included studies</h4> <p>We included eight studies that had 315 adults (299 women) at entry (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>; <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>; <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>; see <a href="./references#CD012172-sec-0145" title="">Characteristics of included studies</a> table). The age of participants was 18 to 75 years in the reports that provided information about the age range of the sample. There were seven RCTs and one quasi‐RCT with sequential allocation to groups (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>). Six studies used a parallel‐group design, and two studies used a cross‐over design (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>). Study sample sizes were between 10 and 66 participants and intervention arm size samples were between five and 43. The period for interventions was 30 minutes (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>), seven days (<a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>), 21 days (<a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>), 42 days (<a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>), and 84 days (although the TENS intervention was only for the first 21 days, <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). The period for interventions used by <a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> was unclear. Assessments of treatment outcome were taken within the intervention period. Only one study conducted a post‐intervention follow‐up, which was for 24 months (<a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>). </p> <p>Six studies used TENS as the sole treatment (<a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>; <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>; <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>), and two studies used TENS in combination with exercise (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). Five studies used high‐frequency TENS (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>), one study used low‐frequency TENS (<a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>), and two studies used both high and low frequencies (<a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>). Six studies used 'strong' intensities (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>), one study used 'constant tingling' (<a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>), and one study used 'pleasant tingling' (<a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>). Pain was recorded using VAS (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>; <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>), NRS (<a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>), or some other pain scale (<a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>; <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). The most commonly used health‐related quality of life was the Fibromyalgia Impact Questionnaire (FIQ) (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). One study reported outcomes during TENS (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>), seven studies reported outcomes post‐TENS (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>; <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>; <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>), and two studies reported outcomes long‐term from nine weeks (<a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>) to 24 months (<a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>). We provided a brief description of each of the included studies below. </p> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> conducted a quasi‐randomised controlled parallel‐group study that enrolled 32 women sequentially allocated to receive an eight‐week programme of aerobic and stretching exercises with or without high‐frequency (150 Hz) TENS applied on bilateral tender points of the trapezium and supraspinatus. Twenty‐eight women completed the study. Exercises with TENS produced a greater decrease in pain intensity and a greater increase in pressure pain threshold at tender points than exercises without TENS. </p> <p><a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a> conducted a parallel‐group RCT that enrolled 10 people to receive hydrotherapy or TENS at a frequency of 15 Hz. TENS was administered as three 40‐minute sessions per week to a total of 10 sessions. TENS reduced pain, and improved functional outcomes and quality of life to a greater extent than hydrotherapy. </p> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> conducted a double‐blinded randomised, placebo‐controlled cross‐over study that enrolled 43 women. Each participant received one 30‐minute intervention per week of either active TENS at 100 Hz, or placebo TENS or no TENS. The order of interventions was randomised and outcome measures taken whilst TENS remained switched on. Two participants did not receive TENS or placebo TENS because of withdrawal from the study. Active TENS produced higher pressure pain thresholds and lower pain intensity and fatigue with movement compared with placebo and no TENS. </p> <p><a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a> conducted a parallel‐group RCT that enrolled 30 people to a six‐week course of either S‐adenosyl‐L‐methionine (SAMe) or TENS at a frequency of 80 Hz to 100 Hz. There were decreases in pain, fatigue, and the number of tender points following SAMe but not during TENS. </p> <p><a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a> conducted a parallel‐group RCT that enrolled 66 people to a 20‐day course of TENS (dermal neurological electric stimulation), electroacupuncture, or routine medication. TENS was administered daily using two electrodes applied near to the most painful site and two electrodes applied to 'supplementary acupuncture points' at a frequency of 100 Hz for 15 minutes followed by a frequency of 2 Hz for 15 minutes. Electroacupuncture was administered using a G‐6805 stimulator and No. 28 filiform needles inserted 'deeply' to the same sites as TENS to generate 'deqi.' Routine medication was administered using oral doses of oryzanol and vitamin B<sub>1</sub> (30 mg), three times a day and amitriptyline titrated to 20 mg to 30 mg once per day. TENS and electroacupuncture reduced pain and recurrence of pain to a greater extent than routine medication. </p> <p><a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> conducted a randomised placebo‐controlled parallel‐group study that enrolled 39 people to one of three interventions: dual‐site TENS of the lower back (L5) and the upper back (C7 and T1); dual‐site placebo (no current) TENS of the lower back (L5) and the upper back (C7 and T1); or single‐site TENS of either the lower back (L5) or upper back (C7 and T1) combined with single‐site placebo (no current) TENS of either the lower back (L5) and the upper back (C7 and T1). Interventions were administered for 20 minutes per day for seven consecutive days. TENS was administered using mixed frequencies of 2 Hz and 100 Hz. For the outcomes associated with pain relief and quality of sleep, dual‐site TENS was superior to single‐site TENS which was superior to dual‐site placebo TENS. </p> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> conducted a randomised controlled cross‐over study that enrolled 32 people to self‐administer a daily treatment of superficial warmth (42 °C) using a portable prototype device or TENS at a frequency of 80 Hz for three weeks with the order of receiving the treatments randomised. Both treatments reduced pain compared with baseline but there were no differences in the amount of pain relief between treatments. </p> <p><a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a> conducted a parallel‐group RCT that enrolled 66 people to a 12‐week course of supervised exercise with or without TENS at a frequency of 80 Hz. TENS was administered daily in the first three weeks of the 12‐week course of exercise. Outcomes for pain, tender point count, FIQ, and SF‐36 improved in both groups. There were superior improvements in outcomes for pain at week three for participants receiving TENS. </p> </section> <section id="CD012172-sec-0059"> <h4 class="title">Excluded studies</h4> <p>We excluded six records after screening the full‐text report (<a href="./references#CD012172-sec-0146" title="">Characteristics of excluded studies</a> table). We excluded one record because we were unable to locate the original source due to an error in the search citation (<a href="./references#CD012172-bbs2-0012" title="MutluB , PakerN , YylmazE , SoyD . Comparison of therapeutic efficacy of transcutaneous electrical nerve stimulation (TENS) and exercise program in fibromyalgia syndrome: a prospective randomized study. Annals of the Rheumatic Diseases2006;65:649‐55. ">Mutlu 2006</a>). We excluded one report that was a commentary of previously published studies (<a href="./references#CD012172-bbs2-0013" title="SimonsDG , DommerholtJ . Myofascial pain syndromes ‐ trigger points. Journal of Musculoskeletal Pain2006;14(1):59‐60. ">Simons 2006</a>), one report of a case series (<a href="./references#CD012172-bbs2-0010" title="IdoCS , RothenbuhlerR , JanzJ , LorisL . Transcutaneous nerve electrostimulation of low frequency to tender points of the juvenile fibromyalgia patients [Eletroestimulação nervosa transcutanea de baixa frequencia nos tender points dos pacientes fibromialgicos juvenis]. Revista Fisioterapia Universidade Sao Paulo2003;10(1):1‐6. ">Ido 2003</a>), one report of a study that was found not to be an RCT (<a href="./references#CD012172-bbs2-0009" title="ArroyoJF , CohenML . Abnormal responses to electrocutaneous stimulation in fibromyalgia. Journal of Rheumatology1993;20(11):1925‐31. ">Arroyo 1993</a>), one report of a study using microcurrent not TENS (<a href="./references#CD012172-bbs2-0014" title="SunshineW , FieldTM , QuintinoO , FierroK , KuhnC , BurmanI , et al. Fibromyalgia benefits from massage therapy and transcutaneous electrical stimulation. Journal of Clinical Rheumatology1996;2(1):18‐22. ">Sunshine 1996</a>), and one report of an RCT where it was not possible to isolate the effects of TENS from other treatment because TENS was given as combination therapy (<a href="./references#CD012172-bbs2-0011" title="KesiktasN , KaragulleZ , ErdoganN , YaziciogluK , YilmazH , PakerN . The efficacy of balneotherapy and physical modalities on the pulmonary system of patients with fibromyalgia. Journal of Back and Musculoskeletal Rehabilitation2011;24(1):57‐65. ">Kesiktas 2011</a>). </p> <section id="CD012172-sec-0060"> <h5 class="title">Ongoing studies</h5> <p>One study was ongoing at the time of this review, for which a protocol had been published (<a href="./references#CD012172-bbs2-0015" title="NoehrenB , DaileyDL , RakelBA , VanceCG , ZimmermanMB , CroffordLJ , et al. Effect of transcutaneous electrical nerve stimulation on pain, function, and quality of life in fibromyalgia: a double‐blind randomized clinical trial. Physical Therapy2015;95(1):129‐40. ">Noehren 2015</a>). The initial phase of the study will randomly allocate 360 participants to receive active TENS, placebo TENS, or standard care (no TENS). See <a href="./references#CD012172-sec-0147" title="">Characteristics of ongoing studies</a> table. </p> </section> </section> </section> <section id="CD012172-sec-0061"> <h3 class="title">Risk of bias in included studies</h3> <p>We judged that there was a high risk of bias in seven of the eight included studies. Our assessment of the risk of bias for the included studies is summarised in <a href="#CD012172-fig-0002">Figure 2</a> and <a href="#CD012172-fig-0003">Figure 3</a>. We judged the study by <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> to have the lowest risk of bias overall, although this study still had a risk of bias due to a small sample size. </p> <div class="figure" id="CD012172-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012172-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012172-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012172-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012172-sec-0062"> <h4 class="title">Allocation</h4> <p>We judged that two studies adequately described the method of random sequence generation (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>) and one study adequately described allocation concealment (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>). We judged one study to have a high risk of selection bias because participants were allocated consecutively into two treatment groups (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>). We judged the remaining studies to be at unclear risk of bias because they did not adequately report the method of random sequence generation and allocation concealment. </p> </section> <section id="CD012172-sec-0063"> <h4 class="title">Blinding</h4> <section id="CD012172-sec-0064"> <h5 class="title">Blinding of participants and personnel (performance bias): participants, and care providers administering TENS </h5> <p>We judged that two studies adequately described the method of blinding of participants (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>) although <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> used TENS with no current and therefore there is a challenge to the success of blinding. Therefore, we judged <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> as low risk of bias, and <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> as unclear risk of bias for this domain. We judged five studies to be at high risk of performance bias because there was no attempt to blind participants or therapists (or both) to treatment groups (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>; <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). We judged the remaining study to be at unclear risk of bias. </p> </section> <section id="CD012172-sec-0065"> <h5 class="title">Blinding of outcome assessment (detection bias): outcome assessors</h5> <p>We judged that two studies adequately described the method of blinding of outcome assessment (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> assessed the success of blinding of outcomes assessors to interventions given simultaneously at two body sites. The success rate of identifying the interventions was 54% and 53% for active TENS, 50% and 34% for placebo TENS and 58% and 50% for no TENS, with no statistically significant differences between treatment groups. We judged two studies to be at high risk of detection bias (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009)</a>. We judged the remaining studies to be at unclear risk of bias. </p> </section> </section> <section id="CD012172-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>We judged three studies to be at low risk of attrition bias because all participants completed the study with no missing outcome data (<a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>; <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>) or missing outcome data were balanced across the groups with similar reasons for loss (<a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). We judged one study to be at high risk of attrition bias because there were substantial data missing at six months', 12 months', and 24 months' follow‐up (<a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>). We judged the remaining studies to be at unclear risk of attrition bias. </p> </section> <section id="CD012172-sec-0067"> <h4 class="title">Selective reporting</h4> <p>We judged one study to be at low risk of reporting bias because there was a protocol registered on ClinicalTrials.gov and analysis of prespecified outcomes were faithfully reported (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>). We judged one study to be at high risk of reporting bias because analyses of some outcomes were not prespecified in the methods section and 100‐mm VAS scores were converted into four arbitrary categories and analysed using frequency counts (<a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>). We judged the remaining studies to be at unclear risk of reporting bias. </p> <section id="CD012172-sec-0068"> <h5 class="title">Sample size</h5> <p>We judged that there was a high risk of bias due to small sample sizes with all eight included studies having fewer than 50 participants per treatment arm. </p> </section> </section> <section id="CD012172-sec-0069"> <h4 class="title">Other potential sources of bias</h4> <p>We judged that there was a risk of bias from treatment carry‐over effects due to the absence of a washout period for <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>. Potential conflicts of interest or industrial sponsorship (or both) were not disclosed in the majority of study reports. <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> and <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> disclosed that TENS units were donated by a TENS company. <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> disclosed that none of the authors had conflicts of interest with respect to the study although two authors had associations with the company that donated the TENS devices. <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a> acknowledged partial study support by BioResearch, Liscate, Italy. </p> </section> </section> <section id="CD012172-sec-0070"> <h3 class="title" id="CD012172-sec-0070">Effects of interventions</h3> <p>See: <a href="./full#CD012172-tbl-0001"><b>Summary of findings for the main comparison</b> TENS compared to placebo TENS for fibromyalgia</a>; <a href="./full#CD012172-tbl-0002"><b>Summary of findings 2</b> TENS compared to no treatment for fibromyalgia</a>; <a href="./full#CD012172-tbl-0003"><b>Summary of findings 3</b> TENS with exercise compared to exercise alone for fibromyalgia</a>; <a href="./full#CD012172-tbl-0004"><b>Summary of findings 4</b> TENS compared to other active treatment for fibromyalgia</a> </p> <p>The authors of seven of the eight included studies concluded that their study provided evidence that TENS was effective at relieving pain associated with fibromyalgia but the studies had very small sample sizes and were underpowered. Small studies are known to be at high risk of producing inaccurate estimates (<a href="./references#CD012172-bbs2-0079" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. ">Moore 1998</a>) and small‐study effects distort the findings of meta‐analyses (<a href="./references#CD012172-bbs2-0017" title="AlBalawiZ , McAlisterFA , ThorlundK , WongM , WetterslevJ . Random error in cardiovascular meta‐analyses: how common are false positive and false negative results?. International Journal Cardiology2013;168(2):1102‐7. ">AlBalawi 2013</a>; <a href="./references#CD012172-bbs2-0098" title="NüeschE , TrelleS , ReichenbachS , RutjesAW , TschannenB , AltmanDG , et al. Small study effects in meta‐analyses of osteoarthritis trials: meta‐epidemiological study. BMJ2010;341:c3515. ">Nüesch 2010</a>). Stronger effect estimates in meta‐analyses are found for small‐sized studies compared with larger studies (<a href="./references#CD012172-bbs2-0038" title="DechartresA , TrinquartL , BoutronI , RavaudP . Influence of trial sample size on treatment effect estimates: meta‐epidemiological study. BMJ2013;346:f2304. ">Dechartres 2013</a>). Thus estimates of efficacy will only be credible if data arise from large studies or from pooling multiple moderately sized studies with similar methodology and comparison groups. The studies in our review did not meet these criteria. We judged that there were too few data from outcomes that were not suitably homogeneous for any meaningful statistical pooling of results. We provide a descriptive narrative of the included studies for completeness (<a href="#CD012172-tbl-0005">Table 1</a>). </p> <div class="table" id="CD012172-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table of results</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Reference</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Details of results for individual studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Greater reductions in pain intensity when TENS was added to an 8‐week programme of aerobic and stretching exercises. A 30% decrease in pain severity was set as a clinically relevant reduction in pain a priori and they reported that 30% of 14 participants in the TENS with exercise group achieved this clinically relevant improvement and this was significantly greater than 13% of 14 participants in the exercise without TENS group. However, these percentages equate to 4.2 participants and 1.82 participants respectively, which is illogical. The mean ± SD reduction in pain intensity was 20 ± 29 mm for TENS and 7.0 ± 37 mm for the without TENS. TENS had improvement in the Fibromyalgia Impact Questionnaire items for pain, work performance, fatigue, stiffness, anxiety, and depression and exercise had improvements for morning tiredness and depression. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TENS group showed significantly less pain after the intervention (mean ± SD: 3.4 ± 2.2 (P &lt; 0.004). Hydrotherapy group showed no difference in VAS scores post‐intervention (mean ± SD: 6.6 ± 1.5). </p> <p>Between‐group comparisons not reported. Hydrotherapy group showed statistically improvement of the SF‐36 total score (P = 0.007) and of the domains physical role (P = 0.002), pain (P = 0.007), vitality (P = 0.001), social aspects (P = 0.04), and emotional role (P = 0.005). There was also an improvement on the scores of the domain emotional reactions of the Nottingham Health Profile (P = 0.036). TENS group showed statistically improvement of the SF‐36 total score (P = 0.006) and of the domains functional capacity (P = 0.018), physical role (P = 0.038), pain (P = 0.001), social aspects (P = 0.02), and emotional role (P = 0.004). There was also an improvement on the scores of the Nottingham Health Profile total score (P = 0.001) and the domains: energy level (P = 0.009), pain (P = 0.004), and emotional reactions (P = 0.03). There was also a significant difference on the Beck Depression Inventory (P = 0.004). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A single 30‐minute treatment of active TENS reduced pain intensity (VAS) on movement compared with placebo TENS with the mean ± SD difference in VAS scores (100 mm) before and during intervention being 11.1 ± 2.6 mm (95% CI 5.9 to 16.3) for TENS and 2.3 ± 2.6 mm (95% CI 2.4 to 7.7) for placebo TENS (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>). There were no significant differences between TENS and placebo TENS for pain at rest. TENS reduced pain intensity (VAS) on movement compared with no‐TENS (2.6 ± 2.5 mm (95% CI 2.8 to 7.5)). There were no significant differences between TENS and no TENS for pain at rest. PPT in the cervical region was significantly increased by active TENS versus control but not versus placebo (P &lt; 0.05). Lumbar region PPT was significantly increased with active TENS versus placebo and control (P &lt; 0.05). PPTs over the anterior tibialis (n = 36) were significantly increased with active TENS versus control (P &lt; 0.05). Fatigue with movement during the 6‐minute walk test was significantly reduced for active TENS compared with placebo TENS (P &lt; 0.005) and for active TENS compared with no TENS (P &lt; 0.001). No significant differences between any groups for range of motion, single leg stance, sit‐to‐stand test, 6‐minute walk test. This study had the lowest risk of bias of the studies included in our review. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The total number of tender points decreased significantly from 10 to 5 only in the SAMe group (P &lt; 0.01) and the 2 groups differed significantly at the end of treatment (P = 0.05) in the total number of tender points (P &lt; 0.05). The total tender point score improved significantly (P &lt; 0.01) during SAMe treatment. The SAMe group also improved significantly in the subjective evaluation and psychiatric rating scales. No significant differences were shown for pain in the TENS group. Within‐group statistics reported for other outcomes. SAMe produced reductions in scores for both the Hamilton Rating Scale for Depression and the Hamilton Rating Scale for Anxiety and by day 14 of treatment. TENS only produced a reduction in the Hamilton Rating Scale for Anxiety score at the end of treatment only. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There were no significant differences between the TENS and electroacupuncture groups (P &gt; 0.05) but both showed significantly positive differences compared with the medical group (P &lt; 0.01). Data were reported for 6, 12, and 24 months. All participants completed the study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean ± SD pain intensity (100‐mm VAS) decreased from 85 ± 20 mm at baseline to 43 ± 20 mm after 1 week of dual‐site TENS (reduction of 49.4%) and decreased from 85 ± 10 mm at baseline to 60 ± 10 mm after 1 week of single‐site TENS (pain reduction of 29%). Placebo TENS decreased from 82 ± 20 mm at baseline to 80 ± 20 mm after 1 week (pain reduction of 2.5%). There were statistically significant differences between groups (P &lt; 0.02). Daily consumption of diclofenac 50 mg was statistically significant between groups (P &lt; 0.05) and lower for both the single‐ and dual‐site TENS compared with placebo‐TENS. Quality of sleep was improved with dual‐site TENS (10 participants) and single‐site TENS (8 participants) and worsened in the placebo TENS group (n = 4; P &lt; 0.05). Quality of fatigue was improved with dual‐site TENS (7 participants) and single‐site TENS (5 participants) but not with placebo‐TENS (n = 0; P &lt; 0.05). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Between‐group differences for pain intensity were not significant. ITT analysis: 10 responders reported a reduction of ≥ 20 points with thermal therapy and 10 responded in the same way with TENS. Per‐protocol analysis: 42% of 24 participants responded to warmth and 36% of 28 responded to TENS (difference between groups was not statistically significant) (P = 0.66). 4 participants were considered responders to both. No difference in duration of pain relief between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The exercise with TENS group showed a more significant improvement in myalgic pain at the end of the 3rd week than the exercise alone group but this decrease in pain was similar in both groups by the end of week 12. Scores in the Fibromyalgia Impact Questionnaire and SF‐36 improved significantly in both groups by the end of the 3rd week. 6 withdrawals reported; 3 from each group. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; SAMe: S‐adenosyl‐L‐methionine; SD: standard deviation; SF‐36: 36‐item Short Form; PPT: pressure pain threshold; TENS: transcutaneous electrical nerve stimulation; VAS: visual analogue scale. </p> </div> </div> <section id="CD012172-sec-0071"> <h4 class="title">TENS compared with placebo TENS (e.g. sham (no current) TENS device)</h4> <p>Two studies included a comparison of TENS versus placebo TENS (54 participants in the placebo TENS arm (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>; <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>). We judged the quality of the evidence using GRADE to be very low; we downgraded three times due to a lack of data (<a href="./full#CD012172-tbl-0001">summary of findings Table for the main comparison</a>). </p> <section id="CD012172-sec-0072"> <h5 class="title">Primary outcomes</h5> <p>None of the included studies measured primary outcomes as dichotomous data (responder analysis). </p> <section id="CD012172-sec-0073"> <h6 class="title">Participant‐reported pain relief of 30% or greater</h6> <p>Neither study measured participant‐reported pain relief of 30% or greater.</p> </section> <section id="CD012172-sec-0074"> <h6 class="title">Participant‐reported pain relief of 50% or greater</h6> <p>Neither study measured participant‐reported pain relief of 50% or greater.</p> </section> <section id="CD012172-sec-0075"> <h6 class="title">PGIC much or very much improved</h6> <p>Neither study measured PGIC much or very much improved.</p> </section> <section id="CD012172-sec-0076"> <h6 class="title">PGIC very much improved</h6> <p>Neither study measured PGIC very much improved.</p> </section> </section> <section id="CD012172-sec-0077"> <h5 class="title">Secondary outcomes</h5> <section id="CD012172-sec-0078"> <h6 class="title">Other pain‐related outcomes</h6> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> found that a single 30‐minute treatment of TENS reduced pain intensity (VAS) on movement compared with placebo TENS with the mean ± standard error of the mean (SEM) difference in VAS scores (100 mm) before and during intervention being 11.1 ± 2.6 mm (95% CI 5.9 to 16.3) for TENS and 2.3 ± 2.6 mm (95% CI 2.4 to 7.7) for placebo TENS. There were no significant differences between TENS and placebo TENS for pain intensity at rest. This double‐blinded randomised, placebo‐controlled cross‐over study of 43 participants was described as a pilot study to inform the design of a larger‐scale clinical study. <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported that active TENS increased pressure pain threshold to a greater extent than placebo TENS in the lumbar region (P &lt; 0.05) but not in the cervical region or anterior tibialis. </p> <p><a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> reported that mean ± standard deviation (SD) pain intensity (100‐mm VAS) decreased from 85 ± 20 mm at baseline to 43 ± 20 mm after one week of dual‐site TENS (reduction 49.4%) and decreased from 85 ± 10 mm at baseline to 60 ± 10 mm after one week of single‐site TENS (pain reduction 29%). Placebo TENS decreased pain intensity (VAS) from 82 ± 20 mm at baseline to 80 ± 20 mm after one week (pain reduction 2.5%). </p> </section> <section id="CD012172-sec-0079"> <h6 class="title">Participant‐reported change in health‐related quality of life</h6> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported that fatigue with movement during the six‐minute walk test was significantly reduced for active TENS compared with placebo TENS (P &lt; 0.05) but not for fatigue at rest. There were no significant differences between any groups for range of motion, single leg stance, sit‐to‐stand test, or six‐minute walk test. </p> <p><a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> reported that quality of sleep was improved in dual‐site TENS (10 participants) and single‐site TENS (eight participants) and worsened in the placebo TENS group (four participants, P &lt; 0.05). 'Quality of fatigue' was improved in dual‐site TENS (seven participants) and single‐site TENS (five participants) but not in the placebo TENS group (zero participants, P &lt; 0.05). However, as quality of fatigue was not defined, it was unclear whether this meant that there was an improvement in level of fatigue. </p> </section> <section id="CD012172-sec-0080"> <h6 class="title">Withdrawals</h6> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported two withdrawals after the no‐TENS intervention (without reasons) resulting in missing data from the TENS and placebo TENS interventions. </p> <p><a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> reported two withdrawals from the placebo TENS group and one withdrawal from the TENS group due to absence of symptom relief. </p> </section> <section id="CD012172-sec-0081"> <h6 class="title">Adverse events</h6> <p><a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> reported that two participants experienced muscle soreness following 70 minutes of TENS and six participants experienced gastric discomfort which they attributed to oral diclofenac (placebo TENS: four participants; single‐site TENS: two participants). The authors stated that no adverse events were observed due to active TENS. </p> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> did not report adverse events. </p> <p><b>Serious adverse events</b> </p> <p>Neither of the included studies reported any serious adverse events.</p> <p><b>Specific adverse events</b> </p> <p><a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> reported that two participants experienced muscle soreness following 70 minutes of TENS. </p> </section> <section id="CD012172-sec-0082"> <h6 class="title">Disability‐related or mental health‐related outcome</h6> <p>Neither study reported disability‐related or mental health‐related outcomes.</p> </section> </section> </section> <section id="CD012172-sec-0083"> <h4 class="title">TENS compared with no treatment or waiting list control</h4> <p>One study included a comparison of TENS against no treatment (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>). We judged the quality of the evidence using GRADE to be very low; we downgraded three times due to a lack of data (<a href="./full#CD012172-tbl-0002">summary of findings Table 2</a>). </p> <section id="CD012172-sec-0084"> <h5 class="title">Primary outcomes</h5> <p>The study did not measure primary outcomes as dichotomous data (responder analysis).</p> <section id="CD012172-sec-0085"> <h6 class="title">Participant‐reported pain relief of 30% or greater</h6> <p>The study did not report participant‐reported pain relief of 30% or greater.</p> </section> <section id="CD012172-sec-0086"> <h6 class="title">Participant‐reported pain relief of 50% or greater</h6> <p>The study did not report participant‐reported pain relief of 50% or greater.</p> </section> <section id="CD012172-sec-0087"> <h6 class="title">PGIC much or very much improved</h6> <p>The study did not report PGIC much or very much improved.</p> </section> <section id="CD012172-sec-0088"> <h6 class="title">PGIC very much improved</h6> <p>The study did not report PGIC very much improved.</p> </section> </section> <section id="CD012172-sec-0089"> <h5 class="title">Secondary outcomes</h5> <section id="CD012172-sec-0090"> <h6 class="title">Other pain‐related outcomes</h6> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> found that a single 30‐minute treatment of TENS reduced pain intensity (VAS) on movement compared with a no‐TENS control with the mean ± standard error of the mean (SEM) difference in VAS scores (100 mm) before and during intervention being 11.1 ± 2.6 mm (95% CI 5.9 to 16.3) for TENS and 2.6 ± 2.5 mm (95% CI 2.8 to 7.5) for no‐TENS. There were no significant differences between TENS and no TENS for pain at rest. <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported that active TENS increased pressure pain threshold to a greater extent than the no‐TENS control in the cervical, lumbar, and anterior tibialis regions (P &lt; 0.05). </p> </section> <section id="CD012172-sec-0091"> <h6 class="title">Participant‐reported change in health‐related quality of life</h6> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported that fatigue with movement during the six‐minute walk test was significantly reduced for active TENS compared with no TENS (P &lt; 0.001) but not for fatigue at rest. There were no significant differences between groups for range of motion, single leg stance, sit‐to‐stand test, or six‐minute walk test. </p> </section> <section id="CD012172-sec-0092"> <h6 class="title">Withdrawals</h6> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported that there were two withdrawals after the no‐TENS intervention (without reasons) resulting in missing data from the TENS and no TENS interventions. </p> </section> <section id="CD012172-sec-0093"> <h6 class="title">Adverse events, serious adverse events, specific adverse events</h6> <p>The study did not report adverse events.</p> </section> <section id="CD012172-sec-0094"> <h6 class="title">Disability‐related or mental health‐related outcome</h6> <p>The study did not report disability‐related or mental health‐related outcomes.</p> </section> </section> </section> <section id="CD012172-sec-0095"> <h4 class="title">TENS added to exercise compared with exercise alone (usual care)</h4> <p>Two studies included a comparison of TENS added to exercise against exercise alone (49 participants enrolled into each treatment arm for both studies combined) (<a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>; <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). We judged the quality of the evidence using GRADE to be very low; we downgraded three times due to a lack of data (<a href="./full#CD012172-tbl-0003">summary of findings Table 3</a>). </p> <section id="CD012172-sec-0096"> <h5 class="title">Primary outcomes</h5> <section id="CD012172-sec-0097"> <h6 class="title">Participant‐reported pain relief of 30% or greater</h6> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>reported that 30% of 14 participants achieved pain relief of 30% or greater when TENS was added to an eight‐week programme of aerobic and stretching exercises compared with 13% of 14 participants in the exercise alone group. These percentages equate to 4.2 participants in the TENS plus exercise group and 1.82 participants in the exercise alone group, which is illogical, and yet the authors did not describe whether they rounded their figures to the nearest whole number. </p> </section> <section id="CD012172-sec-0098"> <h6 class="title">Participant‐reported pain relief of 50% or greater</h6> <p>The studies did not report participant‐reported pain relief of 50% or greater.</p> </section> <section id="CD012172-sec-0099"> <h6 class="title">PGIC much or very much improved</h6> <p>The studies did not report PGIC much or very much improved.</p> </section> <section id="CD012172-sec-0100"> <h6 class="title">PGIC very much improved</h6> <p>The studies did not report PGIC very much improved.</p> </section> </section> <section id="CD012172-sec-0101"> <h5 class="title">Secondary outcomes</h5> <section id="CD012172-sec-0102"> <h6 class="title">Other pain‐related outcomes</h6> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a>reported greater reductions in pain intensity when TENS was added to an eight‐week programme of aerobic and stretching exercises. The mean ± SD reduction in pain intensity was 20 ± 29 mm for TENS with exercise and 7.0 ± 37 mm for exercise alone. There were greater increases in pressure pain threshold at tender points with TENS plus aerobic and stretching exercises. </p> <p><a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a> reported that three weeks of TENS added to the first three weeks of a 12‐week supervised exercise programme produced greater than 30% reduction (relative to baseline) in the degree of tenderness at the tender points (myalgic pain score) measured using a four‐point scale (no pain, mild, moderate, and severe) at the three and 12 weeks measurement time points. There were statistically significant improvements in myalgic pain score and tender point count when TENS was added to exercise compared with exercise alone. </p> </section> <section id="CD012172-sec-0103"> <h6 class="title">Participant‐reported change in health‐related quality of life</h6> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> reported clinically important improvements in subscales for work performance, fatigue, stiffness, anxiety, and depression for TENS with exercise compared with exercise alone. </p> <p><a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a> reported that there was no additional improvements in FIQ scores or SF‐36 when TENS was added to a 12‐week supervised exercise programme. </p> </section> <section id="CD012172-sec-0104"> <h6 class="title">Withdrawals</h6> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> reported two withdrawals and two dropouts in equal numbers from each group with no reasons. </p> <p><a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a> reported three withdrawals from each group stating that there were similar reasons for the withdrawals, although further details were not provided. In all instances missing data were removed from subsequent analysis. </p> </section> <section id="CD012172-sec-0105"> <h6 class="title">Adverse events, serious adverse events, specific adverse events</h6> <p>Neither study reported adverse events, serious adverse events, or specific adverse events. </p> </section> <section id="CD012172-sec-0106"> <h6 class="title">Disability‐related or mental health‐related outcome</h6> <p>Neither study reported disability‐related or mental health‐related outcomes.</p> </section> </section> </section> <section id="CD012172-sec-0107"> <h4 class="title">TENS compared with other treatment</h4> <p>Four studies included a comparison of TENS versus another treatment: hydrotherapy (<a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>), SAMe (<a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>), medication (oryzanol and amitriptyline) or electroacupuncture (<a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>), and superficial warmth (<a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>). We judged the quality of the evidence using GRADE to be very low; we downgraded three times due to a lack of data (<a href="./full#CD012172-tbl-0004">summary of findings Table 4</a>). </p> <section id="CD012172-sec-0108"> <h5 class="title">Primary outcomes</h5> <p>Only one study measured primary outcomes as dichotomous data (responder analysis), but the cut‐off point for response was pain relief of 25% or greater (<a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a>). </p> <section id="CD012172-sec-0109"> <h6 class="title">Participant‐reported pain relief of 30% or greater</h6> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> reported that 10/28 participants achieved pain relief of 20 units or greater on a 100‐unit NRS (i.e. pain relief of 25%) compared with 10/24 participants in the superficial warmth (42 ºC) group with no statistically significant differences between groups. </p> </section> <section id="CD012172-sec-0110"> <h6 class="title">Participant‐reported pain relief of 50% or greater</h6> <p>None of the studies reported participant‐reported pain relief of 50% or greater.</p> </section> <section id="CD012172-sec-0111"> <h6 class="title">PGIC much or very much improved</h6> <p>None of the studies reported PGIC much or very much improved.</p> </section> <section id="CD012172-sec-0112"> <h6 class="title">PGIC very much improved</h6> <p>None of the studies reported PGIC very much improved.</p> </section> </section> <section id="CD012172-sec-0113"> <h5 class="title">Secondary outcomes</h5> <section id="CD012172-sec-0114"> <h6 class="title">Other pain‐related outcomes</h6> <p><a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a> reported that TENS reduced pain, and improved functional outcomes and quality of life to a greater extent than hydrotherapy but treatment arms only had five participants. </p> <p><a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a> reported that SAMe but not TENS reduced the number of tender points. The total number of tender points reduced from 10 to five in the SAMe group. </p> <p><a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a> reported that TENS reduced pain and the recurrence of pain to more than routine medication (oral oryzanol and vitamin B<sub>1</sub> (30 mg three times a day) and amitriptyline (20 mg to 30 mg once per day)). However, it was difficult to interpret the data analysis because pain was measured using VAS but then recategorised into discrete groups ('no effect,' 'effect,' 'remarkable effect,' and 'curing pain'). At 24‐month follow‐up after treatment, the number of participants that the authors described as "cured" or "having significant effects" were 1/14 for TENS, 1/13 for electroacupuncture, and 1/2 for medication. </p> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> did not report other pain‐related outcomes. </p> </section> <section id="CD012172-sec-0115"> <h6 class="title">Participant‐reported change in health‐related quality of life</h6> <p><a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a> reported that SAMe but not TENS reduced fatigue. </p> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> reported improvements in subscales for physical function, number of days felt good after superficial warmth therapy but not TENS, with a strong tendency of the score for depression to increase (worsen) after TENS. </p> <p><a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a> and <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a> did not report participant‐reported change in health‐related quality of life. </p> </section> <section id="CD012172-sec-0116"> <h6 class="title">Withdrawals</h6> <p><a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a> reported missing data for 22 participants at six months' follow‐up, 29 participants at 12 months' follow‐up, and 37 participants at 24 months' follow‐up, although there were no missing data at 45 days' follow‐up. </p> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> reported two withdrawals for reasons "unrelated to treatment." In addition, one participant did not complete the TENS intervention and two participants did not complete the warmth intervention. An ITT and a per‐protocol analysis was conducted although how dropout data were handled was unclear. </p> <p><a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a> and <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a> did not report withdrawals. </p> </section> <section id="CD012172-sec-0117"> <h6 class="title">Adverse events, serious adverse events, specific adverse events</h6> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> reported two adverse events: two participants reported increased pain during TENS. </p> <p><a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>, <a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a>, and <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a> did not report adverse events, serious adverse events, or specific adverse events, </p> </section> <section id="CD012172-sec-0118"> <h6 class="title">Disability‐related or mental health‐related outcome</h6> <p><a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a> reported that TENS produced a reduction in Hamilton Rating Scale for Anxiety score only at the end of treatment whereas SAMe produced reductions in scores for both the Hamilton Rating Scale for Depression and the Hamilton Rating Scale for Anxiety by day 14 of treatment. </p> <p><a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a>, <a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a>, and <a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> did not report disability‐related or mental health‐related outcomes. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012172-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012172-sec-0119"></div> <section id="CD012172-sec-0120"> <h3 class="title" id="CD012172-sec-0120">Summary of main results</h3> <p>The objective of this review was to assess the analgesic efficacy and adverse events of TENS for fibromyalgia in adults. We included seven RCTs and one quasi‐RCT with 315 adults (299 women) and treatment sample sizes between five and 43. No studies measured participant‐reported pain relief of 30% or greater as a dichotomous outcome and no studies measured PGIC, both set as primary outcomes in our review. Seven studies concluded that TENS was effective at relieving pain associated with fibromyalgia but we have very little confidence in these conclusions because sample sizes were too small. There were too few data, and outcomes were not suitably homogeneous, for any meaningful statistical pooling of results. Small studies are known to be at high risk of producing inaccurate estimates (<a href="./references#CD012172-bbs2-0079" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. ">Moore 1998</a>) and small‐study effects distort the findings of meta‐analyses (<a href="./references#CD012172-bbs2-0017" title="AlBalawiZ , McAlisterFA , ThorlundK , WongM , WetterslevJ . Random error in cardiovascular meta‐analyses: how common are false positive and false negative results?. International Journal Cardiology2013;168(2):1102‐7. ">AlBalawi 2013</a>; <a href="./references#CD012172-bbs2-0098" title="NüeschE , TrelleS , ReichenbachS , RutjesAW , TschannenB , AltmanDG , et al. Small study effects in meta‐analyses of osteoarthritis trials: meta‐epidemiological study. BMJ2010;341:c3515. ">Nüesch 2010</a>), with stronger effect estimates in meta‐analyses for small‐sized studies compared with larger studies (<a href="./references#CD012172-bbs2-0038" title="DechartresA , TrinquartL , BoutronI , RavaudP . Influence of trial sample size on treatment effect estimates: meta‐epidemiological study. BMJ2013;346:f2304. ">Dechartres 2013</a>). Estimates of efficacy are only credible when data arise from large studies or from pooling multiple moderately sized studies with similar methodology and comparison groups. The studies in our review did not meet these criteria. Thus, the quality of the evidence was very low when assessed using GRADE. The study with the lowest risk of bias overall was a double‐blind randomised, placebo‐controlled cross‐over pilot study of 43 participants that found that a single 30‐minute treatment of TENS reduced movement‐related pain intensity and fatigue and increased pressure pain thresholds compared with placebo TENS (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>). There were no reports of participants experiencing any serious adverse events during TENS, although in our experience, adverse events are generally poorly reported. Four specific adverse events were recorded: two participants experienced muscle soreness following 70 minutes of TENS (<a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a>) and two participants reported increased pain during TENS (<a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a>). </p> </section> <section id="CD012172-sec-0121"> <h3 class="title" id="CD012172-sec-0121">Overall completeness and applicability of evidence</h3> <p>There was insufficient robust evidence to support or refute the use of TENS for fibromyalgia. At face value, the methodology used in the studies appeared robust but on closer inspection study reports lacked clarity and detail. Replication of most studies would be impossible. Many study reports lacked fundamental information about pain outcomes such as whether scores were for: pain severity or some other aspect (e.g. bothersomeness); retrospective pain (over what duration) or present pain; pain at rest or on movement; generalised pain or localised pain; mean pain or worst pain. The precise instructions given to participants about how to rate pain severity were rarely reported. The timings of pain measurement varied across studies and sometimes it was not possible to ascertain whether pain outcomes were measured during or after TENS. This is crucial because studies suggest that maximum pain relief is obtained while TENS is switched on (i.e. during TENS; <a href="./references#CD012172-bbs2-0062" title="JohnsonMI . Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014. ">Johnson 2014</a>). </p> <p>There is a decline in the number of people that use TENS over time <a href="./references#CD012172-bbs2-0062" title="JohnsonMI . Transcutaneous Electrical Nerve Stimulation (TENS). Research to Support Clinical Practice. 1st Edition. Oxford(UK): Oxford University Press, 2014. ">Johnson 2014</a> though a small proportion of people continue to use TENS for chronic pain for many years <a href="./references#CD012172-bbs2-0019" title="BatesJA , NathanPW . Transcutaneous electrical nerve stimulation for chronic pain. Anaesthesia1980;35(8):817‐22. ">Bates 1980</a>; <a href="./references#CD012172-bbs2-0058" title="JohnsonMI , AshtonCH , ThompsonJW . Long‑term use of TENS at Newcastle Pain Relief Clinic. Journal of the Royal Society of Medicine1992;85:267‐8. ">Johnson 1992</a>. For this reason, short‐term studies on fibromyalgia, such as those included in this Cochrane Review, are of limited value when assessing TENS for chronic pain. More studies are needed to address issues such as frequency and duration of TENS treatment as a long‐term intervention. Evidence from one Cochrane Review of 19 short‐term studies provided tentative evidence that TENS as a stand‐alone treatment reduces pain intensity over and above that seen with placebo (no current) for acute pain in adults, although small sample sizes prevented definitive conclusions (<a href="./references#CD012172-bbs2-0063" title="JohnsonMI , PaleyCA , HoweTA , SlukaKA . Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD006142.pub3] ">Johnson 2015a</a>). </p> <p>There was variation in the design of TENS treatments across studies and reports lacked specific details of the parameters and techniques used for TENS. Blinding is a challenge in TENS studies because participants experience a TENS sensation during treatment. The study by <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> included in this review was an exemplar of good practice when designing, operationalising, and assessing blinding in TENS studies. They used an authentic sham TENS device that delivered a current for a short period of time before declining to zero current output. They also monitored the success of blinding post‐intervention. </p> </section> <section id="CD012172-sec-0122"> <h3 class="title" id="CD012172-sec-0122">Quality of the evidence</h3> <p>The quality of the evidence was very low when assessed using GRADE, due to a lack of data. There were fewer than 400 participants for continuous data and 300 events for dichotomous data, and more than 25% of participants were included in studies with unclear or high risk of bias. There was a high risk of bias due to inadequate sample size and for blinding. There was no single study with low risk of bias for all items. </p> </section> <section id="CD012172-sec-0123"> <h3 class="title" id="CD012172-sec-0123">Potential biases in the review process</h3> <p>Review authors were not blinded from authors' names, institutions, and journal name or study results at any stage of the review process. Pairs of review authors undertook each stage of the review process independently, including robust searches of databases and a wide variety of sources, and we compared the outcomes. </p> </section> <section id="CD012172-sec-0124"> <h3 class="title" id="CD012172-sec-0124">Agreements and disagreements with other studies or reviews</h3> <p>Cochrane Reviews on TENS for specific types of pain have been inconclusive due to insufficient evidence for phantom and stump pain in adults (<a href="./references#CD012172-bbs2-0064" title="JohnsonMI , MulveyMR , BagnallAM . Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults. Cochrane Database of Systematic Reviews2015, Issue 8. [DOI: 10.1002/14651858.CD007264.pub3] ">Johnson 2015b</a>), and cancer pain in adults (<a href="./references#CD012172-bbs2-0056" title="HurlowA , BennettMI , RobbKA , JohnsonMI , SimpsonKH , OxberrySG . Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD006276.pub3] ">Hurlow 2012</a>). Superiority of TENS over placebo has been reported by non‐Cochrane meta‐analyses for chronic musculoskeletal pain (<a href="./references#CD012172-bbs2-0059" title="JohnsonM , MartinsonM . Efficacy of electrical nerve stimulation for chronic musculoskeletal pain: a meta‐analysis of randomized controlled trials. Pain2007;130(1‐2):157‐65. ">Johnson 2007</a>), and osteoarthritis of the knee (<a href="./references#CD012172-bbs2-0025" title="BjordalJM , JohnsonMI , Lopes‐MartinsRA , BogenB , ChowR , LjunggrenAE . Short term efficacy of physical interventions in osteoarthritis knee pain: a systematic review and meta‐analysis of randomised placebo‐controlled trials. BMC Musculoskeletal Disorders2007;22(8):8‐51. ">Bjordal 2007</a>). One Cochrane protocol for an overview of Cochrane Reviews for TENS for chronic pain has been published (<a href="./references#CD012172-bbs2-0029" title="CatleyMJ , GibsonW , WandBM , MeadsC , O'ConnellNE . Transcutaneous Electrical Nerve Stimulation (TENS) for chronic pain ‐ an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011890] ">Catley 2015</a>), and there are published protocols for TENS for chronic neck pain (<a href="./references#CD012172-bbs2-0102" title="PorfírioGJM , MartimbiancoALC , BrønfortG , TorloniMR , RieraR . Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD011927] ">Porfírio 2015</a>) and TENS for neuropathic pain in adults (<a href="./references#CD012172-bbs2-0046" title="GibsonW , WandBM , O'ConnellNE . Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database of Systematic Reviews2017, Issue 9. [DOI: 10.1002/14651858.CD011976] ">Gibson 2017</a>). One Cochrane Review on TENS of 19 RCTs (1346 participants) provides tentative evidence that TENS as a stand‐alone treatment reduces pain intensity for acute pain in adults, although there was a high risk of bias associated with inadequate sample sizes that made definitive conclusions impossible (<a href="./references#CD012172-bbs2-0063" title="JohnsonMI , PaleyCA , HoweTA , SlukaKA . Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD006142.pub3] ">Johnson 2015a</a>). The systematic review and guideline for fibromyalgia published by <a href="./references#CD012172-bbs2-0121" title="WinkelmannA , HäuserW , FriedelE , Moog‐EganM , SeegerD , SettanM , et al. Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta‐analysis and guideline [Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften]. Schmerz (Berlin, Germany)2012;26(3):276‐86. ">Winkelmann 2012</a> did not recommend TENS as a treatment for fibromyalgia pain due to low‐quality evidence and the updated German guidelines for fibromyalgia gave a negative recommendation for TENS (<a href="./references#CD012172-bbs2-0122" title="WinkelmannA , BorkH , BrückleW , DexlC , HeldmannP , HenningsenP , et al. Physiotherapy, occupational therapy and physical procedures for fibromyalgia syndrome [Physiotherapie, Ergotherapie und physikalische Verfahren beim Fibromyalgiesyndrom]. Schmerz (Berlin, Germany)2017;31(3):255‐65. ">Winkelmann 2017</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012172-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/urn:x-wiley:14651858:media:CD012172:CD012172-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_t/tCD012172-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012172-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012172-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/urn:x-wiley:14651858:media:CD012172:CD012172-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_t/tCD012172-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012172-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012172-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/urn:x-wiley:14651858:media:CD012172:CD012172-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_t/tCD012172-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012172-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/media/CDSR/CD012172/image_n/nCD012172-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012172-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">TENS compared to placebo TENS for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>TENS compared to placebo TENS for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with fibromyalgia </p> <p><b>Setting:</b> hospital and university clinic </p> <p><b>Intervention:</b> TENS </p> <p><b>Comparison:</b> placebo TENS </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Probable outcome with TENS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Probable outcome with placebo TENS</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 30%</b> (≥ 30% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 50%</b> (≥ 50% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC much or very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>In a cross‐over study, <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported 2 withdrawals after the no‐TENS intervention (without reasons) resulting in missing data from the TENS and placebo TENS interventions. <a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> reported 2 withdrawals from the placebo TENS group and 1 withdrawal from the TENS group due to absence of symptom relief. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54 participants per treatment arm</p> <p>(2 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>PGIC:</b> Patient Global Impression of Change; <b>RCT:</b> randomised controlled trial; <b>TENS:</b> transcutaneous electrical nerve stimulation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">TENS compared to placebo TENS for fibromyalgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012172-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">TENS compared to no treatment for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>TENS compared to no treatment for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with fibromyalgia </p> <p><b>Setting:</b> university clinic </p> <p><b>Intervention:</b> TENS </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probably outcome with TENS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Probable outcome with no treatment </b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 30%</b> (≥ 30% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 50%</b> (≥ 50% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC much or very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>In a cross‐over study, <a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> reported that there were 2 withdrawals after the no‐TENS intervention (without reasons) resulting in missing data from the TENS and placebo TENS interventions. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>PGIC:</b> Patient Global Impression of Change; <b>RCT:</b> randomised controlled trial; <b>TENS:</b> transcutaneous electrical nerve stimulation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">TENS compared to no treatment for fibromyalgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012172-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">TENS with exercise compared to exercise alone for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>TENS with exercise compared to exercise alone for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with fibromyalgia </p> <p><b>Setting:</b> hospital and university clinic </p> <p><b>Intervention:</b> TENS with exercise </p> <p><b>Comparison:</b> exercise on its own </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probably outcome with TENS with exercise</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Probable outcome with exercise on its own</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 30%</b> (≥ 30% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> reported that 30% of 14 participants in the TENS with exercise group achieved ≥ 30% reduction in pain and this was significantly greater than 13% of 14 participants in the exercise without TENS group. However, these percentages equate to 4.2 participants and 1.82 participants respectively, which is illogical. The mean ± SD reduction in pain intensity was 20 ± 29 mm for TENS and 7.0 ± 3 7 mm for the exercise without TENS. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 50%</b> (≥ 50% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b>LOW </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC much or very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> reported 2 withdrawals and 2 dropouts in equal numbers from each group with no reasons. <a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a> reported 3 withdrawals from the exercise alone group and 3 withdrawals from the exercise with TENS groups stating that there were similar reasons for the withdrawals, although further details were not provided. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>PGIC:</b> Patient Global Impression of Change; <b>RCT:</b> randomised controlled trial; <b>SD:</b> standard deviation; <b>TENS:</b> transcutaneous electrical nerve stimulation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">TENS with exercise compared to exercise alone for fibromyalgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012172-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">TENS compared to other active treatment for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>TENS compared to another treatment for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with fibromyalgia<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> TENS<br/> <b>Comparison:</b> another treatment (e.g. superficial warmth, hydrotherapy, electroacupuncture, medication) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probably outcome with TENS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probably outcome with another treatment</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 30%</b> (≥ 30% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> reported that post‐TENS 10/28 participants analysed achieved a decrease in pain severity of ≥ 20 units on a 100‐unit NRS (i.e. pain relief of 25%) compared with 10/24 participants in the superficial warmth (42 °C) group with no statistically significant differences between the groups. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported pain relief ≥ 50%</b> (≥ 50% pain relief) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC much or very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PGIC very much improved</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> reported that 2 participants reported increased pain during TENS. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by 3 levels due to small number of studies, participants, and events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NRS:</b> numerical rating scale; <b>PGIC:</b> Patient Global Impression of Change; <b>TENS:</b> transcutaneous electrical nerve stimulation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">TENS compared to other active treatment for fibromyalgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012172-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table of results</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Reference</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Details of results for individual studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0001" title="CarbonarioF , MatsutaniLA , YuanSLK , MarquesAP . Effectiveness of high‐frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. European Journal of Physical and Rehabilitation Medicine2013;49:197‐204. ">Carbonario 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Greater reductions in pain intensity when TENS was added to an 8‐week programme of aerobic and stretching exercises. A 30% decrease in pain severity was set as a clinically relevant reduction in pain a priori and they reported that 30% of 14 participants in the TENS with exercise group achieved this clinically relevant improvement and this was significantly greater than 13% of 14 participants in the exercise without TENS group. However, these percentages equate to 4.2 participants and 1.82 participants respectively, which is illogical. The mean ± SD reduction in pain intensity was 20 ± 29 mm for TENS and 7.0 ± 37 mm for the without TENS. TENS had improvement in the Fibromyalgia Impact Questionnaire items for pain, work performance, fatigue, stiffness, anxiety, and depression and exercise had improvements for morning tiredness and depression. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0003" title="daSilvaTFG , SudaEY , MarçuloCA , PaesFHS , PinheiroGT . Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa2008;15(2):118‐24. ">da Silva 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TENS group showed significantly less pain after the intervention (mean ± SD: 3.4 ± 2.2 (P &lt; 0.004). Hydrotherapy group showed no difference in VAS scores post‐intervention (mean ± SD: 6.6 ± 1.5). </p> <p>Between‐group comparisons not reported. Hydrotherapy group showed statistically improvement of the SF‐36 total score (P = 0.007) and of the domains physical role (P = 0.002), pain (P = 0.007), vitality (P = 0.001), social aspects (P = 0.04), and emotional role (P = 0.005). There was also an improvement on the scores of the domain emotional reactions of the Nottingham Health Profile (P = 0.036). TENS group showed statistically improvement of the SF‐36 total score (P = 0.006) and of the domains functional capacity (P = 0.018), physical role (P = 0.038), pain (P = 0.001), social aspects (P = 0.02), and emotional role (P = 0.004). There was also an improvement on the scores of the Nottingham Health Profile total score (P = 0.001) and the domains: energy level (P = 0.009), pain (P = 0.004), and emotional reactions (P = 0.03). There was also a significant difference on the Beck Depression Inventory (P = 0.004). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A single 30‐minute treatment of active TENS reduced pain intensity (VAS) on movement compared with placebo TENS with the mean ± SD difference in VAS scores (100 mm) before and during intervention being 11.1 ± 2.6 mm (95% CI 5.9 to 16.3) for TENS and 2.3 ± 2.6 mm (95% CI 2.4 to 7.7) for placebo TENS (<a href="./references#CD012172-bbs2-0002" title="DaileyD , RakelB , VanceC , LeeJ , LiebanoR , AnandA , et al. Transcutaneous electrical nerve stimulation (TENS) reduces pain and improves function in people with fibromyalgia. Journal of Pain2011;12:23. DaileyDL , RakelBA , VanceCGT , LiebanoRE , AmritAS , BushHM , et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain2013;154:2554‐62. VanceC , DaileyD , RakelB , GeaslandK , DarghosianL , Alemo MuntersL , et al. A novel method to obtain higher intensity TENS stimulation in clinical application. Journal of Pain2015;1:S93. ">Dailey 2013</a>). There were no significant differences between TENS and placebo TENS for pain at rest. TENS reduced pain intensity (VAS) on movement compared with no‐TENS (2.6 ± 2.5 mm (95% CI 2.8 to 7.5)). There were no significant differences between TENS and no TENS for pain at rest. PPT in the cervical region was significantly increased by active TENS versus control but not versus placebo (P &lt; 0.05). Lumbar region PPT was significantly increased with active TENS versus placebo and control (P &lt; 0.05). PPTs over the anterior tibialis (n = 36) were significantly increased with active TENS versus control (P &lt; 0.05). Fatigue with movement during the 6‐minute walk test was significantly reduced for active TENS compared with placebo TENS (P &lt; 0.005) and for active TENS compared with no TENS (P &lt; 0.001). No significant differences between any groups for range of motion, single leg stance, sit‐to‐stand test, 6‐minute walk test. This study had the lowest risk of bias of the studies included in our review. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0004" title="DiBenedettoP , IonaLG , ZidarichV . Clinical evaluation of S‐adenosyl‐L‐methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research1993;53(2):222‐9. ">Di Benedetto 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The total number of tender points decreased significantly from 10 to 5 only in the SAMe group (P &lt; 0.01) and the 2 groups differed significantly at the end of treatment (P = 0.05) in the total number of tender points (P &lt; 0.05). The total tender point score improved significantly (P &lt; 0.01) during SAMe treatment. The SAMe group also improved significantly in the subjective evaluation and psychiatric rating scales. No significant differences were shown for pain in the TENS group. Within‐group statistics reported for other outcomes. SAMe produced reductions in scores for both the Hamilton Rating Scale for Depression and the Hamilton Rating Scale for Anxiety and by day 14 of treatment. TENS only produced a reduction in the Hamilton Rating Scale for Anxiety score at the end of treatment only. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0005" title="GuoXJ , JiaJ . Comparison of therapeutic effects of transcutaneous electrical nerve stimulation and electroacupuncture on fibromyalgia syndrome. Zhongguo Zhen Jiu2003;23(11):653‐4. GuoXJ , JiaJ . Comparison of therapeutic effects on fibromyalgia syndrome between dermal‐neurological electric stimulation and electric acupuncture. Chinese Journal of Clinical Rehabilitation2005;9(46):171‐3. ">Guo 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>There were no significant differences between the TENS and electroacupuncture groups (P &gt; 0.05) but both showed significantly positive differences compared with the medical group (P &lt; 0.01). Data were reported for 6, 12, and 24 months. All participants completed the study. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0006" title="LaurettiGR , ChubaciEF , MattosAL . Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatology International2013;33:2117‐22. ">Lauretti 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean ± SD pain intensity (100‐mm VAS) decreased from 85 ± 20 mm at baseline to 43 ± 20 mm after 1 week of dual‐site TENS (reduction of 49.4%) and decreased from 85 ± 10 mm at baseline to 60 ± 10 mm after 1 week of single‐site TENS (pain reduction of 29%). Placebo TENS decreased from 82 ± 20 mm at baseline to 80 ± 20 mm after 1 week (pain reduction of 2.5%). There were statistically significant differences between groups (P &lt; 0.02). Daily consumption of diclofenac 50 mg was statistically significant between groups (P &lt; 0.05) and lower for both the single‐ and dual‐site TENS compared with placebo‐TENS. Quality of sleep was improved with dual‐site TENS (10 participants) and single‐site TENS (8 participants) and worsened in the placebo TENS group (n = 4; P &lt; 0.05). Quality of fatigue was improved with dual‐site TENS (7 participants) and single‐site TENS (5 participants) but not with placebo‐TENS (n = 0; P &lt; 0.05). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0007" title="LofgrenM , NorrbrinkC . Pain relief in women with fibromyalgia: a cross‐over study of superficial warmth stimulation and transcutaneous electrical nerve stimulation. Journal of Rehabilitation Medicine2009;41(7):557‐62. ">Lofgren 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Between‐group differences for pain intensity were not significant. ITT analysis: 10 responders reported a reduction of ≥ 20 points with thermal therapy and 10 responded in the same way with TENS. Per‐protocol analysis: 42% of 24 participants responded to warmth and 36% of 28 responded to TENS (difference between groups was not statistically significant) (P = 0.66). 4 participants were considered responders to both. No difference in duration of pain relief between groups. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012172-bbs2-0008" title="MutluB , PakerN , BugdayciD , TekdosD , KesiktasN . Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatology International2013;33:649‐55. ">Mutlu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The exercise with TENS group showed a more significant improvement in myalgic pain at the end of the 3rd week than the exercise alone group but this decrease in pain was similar in both groups by the end of week 12. Scores in the Fibromyalgia Impact Questionnaire and SF‐36 improved significantly in both groups by the end of the 3rd week. 6 withdrawals reported; 3 from each group. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>CI: confidence interval; SAMe: S‐adenosyl‐L‐methionine; SD: standard deviation; SF‐36: 36‐item Short Form; PPT: pressure pain threshold; TENS: transcutaneous electrical nerve stimulation; VAS: visual analogue scale. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table of results</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012172.pub2/full#CD012172-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012172.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012172-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012172-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD012172-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD012172-note-0002">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012172-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012172-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012172\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012172\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012172\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012172\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012172\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012172.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012172.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012172.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012172.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012172.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727871949"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012172.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727871952"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012172.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb6a9b8e09368',t:'MTc0MDcyNzg3Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 